New battery gobbles up carbon dioxide

Your daily selection of the latest science news!

According to (This article and its images were originally posted on Phys.org September 21, 2018 at 01:51PM.)

(Cover Image)

This scanning electron microscope image shows the carbon cathode of a carbon-dioxide-based battery made by MIT researchers, after the battery was discharged. It shows the buildup of carbon compounds on the surface, composed of carbonate material that could be derived from power plant emissions, compared to the original pristine surface (inset). Credit: Massachusetts Institute of Technology

A new type of battery developed by researchers at MIT could be made partly from carbon dioxide captured from power plants. Rather than attempting to convert carbon dioxide to specialized chemicals using metal catalysts, which is currently highly challenging, this battery could continuously convert carbon dioxide into a solid mineral carbonate as it discharges.

While still based on early-stage research and far from commercial deployment, the new formulation could open up new avenues for tailoring electrochemical conversion reactions, which may ultimately help reduce the emission of the greenhouse gas to the atmosphere.

 

|

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com.

To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.
__

This article and its images were originally posted on [Phys.org] September 21, 2018 at 01:51PM. Credit to the original author and Phys.org | ESIST.T>G>S Recommended Articles Of The Day.

 

Donations are appreciated and go directly to supporting ESIST.Tech. Thank you in advance for helping us to continue to be a part of your online entertainment!

 

 

 

Too Good to Be True? A Nonaddictive Opioid without Lethal Side Effects Shows Promise

Your daily selection of the latest science news!

According to (This article and its images were originally posted on Scientific American Content September 5, 2018 at 06:47AM.)

With nearly 50,000 drug overdose deaths from opioids last year and an estimated two million Americans addicted, the opioid crisis continues to rage throughout the U.S. This statistic must be contrasted with another: 25 million Americans live with daily chronic pain, for which few treatment options are available apart from opioid medications.

Opioid drugs like morphine and Oxycontin are still held as the gold standard when it comes to relieving pain. But it has become brutally obvious that opioids have dangerous side effects, including physical dependence, addiction and the impaired breathing that too often leads to death from an overdose. Researchers have long been searching for a drug that would relieve pain without such a heavy toll, with few results so far.

|

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com.

To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.
__

This article and its images were originally posted on [Scientific American Content] September 5, 2018 at 06:47AM. All credit to both the author Stephani Sutherland and Scientific American Content | ESIST.T>G>S Recommended Articles Of The Day.

 

Donations are appreciated and go directly to supporting ESIST.Tech. Thank you in advance for helping us to continue to be a part of your online entertainment!

 

 

 

NASA’s $1 Million Mars-Settling Challenge: Turn CO2 into Sugar

Your daily selection of the latest science news!

According to (This article and its images were originally posted on Space.com September 5, 2018 at 06:50AM.)

(Cover Image)

An artist’s illustration of astronaut pioneers on Mars. Building a self-sustaining settlement on the Red Planet will require taking advantage of native Martian resources, exploration advocates stress.

Credit: Pat Rawlings/NASA

If you know your way around a chemistry lab, you could help humanity set up shop on Mars — and make some serious cash in the process.

NASA is challenging people throughout the United States to come up with a new and efficient way to convert carbon dioxide into glucose, a simple sugar. CO2 dominates the thin atmosphere of Mars, and energy-rich glucose is a great fuel for microbe-milking “bioreactors” that could manufacture a variety of items for future settlers of the Red Planet, NASA officials said.

“Enabling sustained human life on another planet will require a great deal of resources, and we cannot possibly bring everything we will need. We have to get creative,” said Monsi Roman, program manager of NASA’s Centennial Challenges program, which is running the new $1 million “CO2 Conversion Challenge.” [8 Cool Mars Destinations Humans Could Explore]

Follow Mike Wall on Twitter @michaeldwall and Google+. Follow us @Spacedotcom, Facebook or Google+. Originally published on Space.com.

 

|

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com.

To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.
__

This article and its images were originally posted on [Space.com] September 5, 2018 at 06:50AM. All credit to both the author Mike Wall,  @michaeldwall and Space.com | ESIST.T>G>S Recommended Articles Of The Day.

 

Donations are appreciated and go directly to supporting ESIST.Tech. Thank you in advance for helping us to continue to be a part of your online entertainment!

 

 

 

This Industrial Blue Dye Could Help Us Build Better Batteries

Your daily selection of the hottest trending tech news!

According to (This article and its images were originally posted on Futurism August 29, 2018 at 10:57AM.)

SOME POSITIVE PRESS. Usually, when methylene blue makes the news, it’s because the industrial dye has polluted some waterways or hurt some living organisms. But now, researchers from the University at Buffalo think they’ve found a way for the dye to actually help the environment: storing and releasing energy.

They published their research in the journal ChemElectroChem on August 13.

BLUE IS THE POLLUTION-IEST COLOR. Textile mills often use methylene blue to dye fabric (you guessed it) blue. Sometimes, the leftover dye can make its way from the mill into the environment, where it is not easy to clean up.

|
+ Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com.

To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.

__

This article and images were originally posted on [Futurism] August 29, 2018 at 10:57AM. Credit to Author Kristin Houser and Futurism | ESIST.T>G>S Recommended Articles Of The Day.

 

Donations are appreciated and go directly to supporting ESIST.Tech. Thank you in advance for helping us to continue to be a part of your online entertainment!

 

 

 

Drought increases CO2 concentration in the air

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories (This article and its images were originally posted on Phys.org – latest science and technology news stories August 30, 2018 at 05:30AM.) -Cover image via Los Angeles Times

https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/2018/droughtincre.jpg
Land ecosystems are important for the absorption of anthropogenic CO2 emissions. Credit: ETH Zurich

ETH researchers have shown that during drier years, the concentration of carbon dioxide in the atmosphere rises faster because stressed ecosystems absorb less carbon. This global effect is so strong that it must be integrated in the next generation of climate models.

Land ecosystems absorb on average 30 percent of anthropogenic CO2 emissions, thereby tempering the increase of CO2 concentration in the atmosphere. But plants need water to grow. When a drought occurs and soils dry out, plants reduce photosynthesis and respiration in order to conserve water and preserve tissues. As a consequence, they are no longer able to capture from the surrounding air. While this effect can be easily observed in the lab, measuring its impact on the whole planet has proved quite difficult. One of the greatest challenges has been to measure where and how often droughts occur globally. In a new study, Vincent Humphrey, climate researcher in the lab of Sonia Seneviratne, Professor for Land-Climate Dynamics at ETH Zurich, used innovative satellite technology to measure the global sensitivity of ecosystems to water stress. The study was carried out in collaboration with the Laboratoire des Sciences du Climat et de l’Environnement (France) and the University of Exeter (United Kingdom).

Using satellites to measure droughts

Plants are usually able to access water deep in the soil through their roots. However, conventional satellites only see what happens at the surface and cannot measure how much water is available underground. In the last few years, a new type of satellite mission has been used to measure extremely small changes in the Earth’s . It was found that some small perturbations of the gravity field are caused by changes in . When there is a major drought in a given region, there is less water mass and gravity is consequently slightly weaker over that region. Such variations are so small that they are imperceptible to humans. But by measuring them with satellites, scientists are able to estimate large-scale changes in water storage to an accuracy of about four centimetres everywhere on the planet.

Using these new satellite observations of storage, Vincent Humphrey and his colleagues were able to measure the overall impact of droughts on photosynthesis and ecosystem respiration. They compared year-to-year changes in total over all continents against global measurements of CO2 increase in the atmosphere. They found that during the driest years, such as 2015, natural ecosystems removed about 30 percent percent less carbon from the atmosphere than during a normal year. As a result, the concentration of CO2 in the atmosphere increased faster in 2015 compared to normal years. At the other end of the scale, during the wettest year on record in 2011, CO2 concentrations increased at a much slower rate due to healthy vegetation. These results help us understand why atmospheric CO2 growth can vary a lot from one year to the other, even though CO2 emissions from human activities are comparatively stable.

The map shows anomalies in water storage estimated from perturbations of the Earth’s gravity field. The year 2015 was particularly dry on average, with intense droughts over South America, South Africa and Eastern Europe. Credit: Visualizations: ETH Zurich/Vincent Humphrey; data: NASA-GSFC

Crucial for monitoring emissions

 

During the last century, the concentration of CO2 in the atmosphere has been steadily increasing because of human activities. “Now that most countries around the world have agreed they should limit CO2 emissions, we are facing the challenge of monitoring human CO2 emissions to a level of accuracy higher than ever before,” says Vincent Humphrey. In order to precisely evaluate the impact of climate policies, researchers must first develop vegetation models that can quantify and predict the perturbations introduced each year by . “Thanks to our new results, we can now prove that the effects of droughts are stronger than has so far been estimated by vegetation models,” says Sonia Seneviratne. Ultimately, these observations will be integrated into the next generation of models. They should improve the ability to track CO2 emissions and verify that they meet the targets set in international climate agreements.

Continue reading… | Stay even more current with our live science feed.

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com.

To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.
__

This article and its images were originally posted on [Phys.org – latest science and technology news stories] August 30, 2018 at 05:30AM. All credit to both the author TH Zurich and Phys.org – latest science and technology news stories | ESIST.T>G>S Recommended Articles Of The Day.

 

Donations are appreciated and go directly to supporting ESIST.Tech. Thank you in advance for helping us to continue to be a part of your online entertainment!

 

 

 

Coconut Oil Is “Pure Poison”, Says Harvard Professor

Your daily selection of the latest science news!

According to ScienceAlert (This article and its images were originally posted on ScienceAlert August 22, 2018 at 03:05AM.)

A 50-minute German lecture becoming a viral hit on YouTube might sound unusual, but the title of the talk by Karin Michels, the director of the Institute for Prevention and Tumor Epidemiology at the University of Freiburg and a professor at the Harvard TH Chan School of Public Health, has caused a bit of a stir online.

During the lecture, titled “Coconut Oil and other Nutritional Errors,” Michels has made herself very clear with regard to dietary recommendations, and underlined that coconut oil is not healthy.

Its superfood status had already come under scrutiny last year after the American Heart Association (AHA) updated its guidelines, which recommended that people avoid the saturated fatty acids found in coconut oil.

‘Coconut oil is pure poison’

Michels went a step further than to recommend avoiding the foodstuff, saying “coconut oil is pure poison” and “is one of the worst foods you can eat.”

There’s no study showing significant health benefits to coconut-oil consumption. And, according to Michels, coconut oil is more dangerous than lard because it almost exclusively contains saturated fatty acids, ones that can clog the coronary arteries.

You can identify fats that contain large quantities of saturated fatty acids by checking to see whether they remain solid at room temperature, as is the case with butter or lard.

Based on the fact that they contain a lot of unsaturated fatty acids, experts recommend olive or rapeseed oil as an alternative, and while it can’t be used for cooking, flaxseed oil is rich in omega-3 fatty acids and is just as good for the body.

While Michels doesn’t describe other “superfoods” like acai, chia seeds, or matcha as harmful, at most she considers them ineffective because, in most cases, the nutrients they’re touted for are available just as readily in other foods that are more easily accessible such as carrots, cherries, and apricots.

“We are well and sufficiently supplied,” she said.

Are saturated fats really that unhealthy?

Most researchers agree that olive oil or linseed oil can form an important part of a healthy diet. While the scientific world is still debating whether saturated fatty acids really are the work of the devil, others say with certainty that that’s the case.

However, a study published in the American Journal of Clinical Nutrition indicated that people who routinely consume cheese, whole milk, and other high-fat dairy products – in essence, products high in saturated fatty acids – are at no higher risk of dying from a heart attack, stroke, or other illness than those who avoid such products.

Another study using data from 135,000 people in 18 countries and published in The Lancet, found that high fat and low carbohydrate consumption were associated with a 23 percent lower risk of death. And, even more exciting, the positive effect still stands, regardless of whether saturated or unsaturated fatty acids are being consumed.

So what’s the actual verdict on coconut oil? Most international dietary guidelines recommend enjoying saturated fats in moderation.

As the saying goes, the dose makes the poison, so if you do have a soft spot for coconut oil, just take care not to overindulge.

This article was originally published by Business Insider Deutschland.

Continue reading… | Stay even more current with our live science feed.

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com.

To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.
__

This article and its images were originally posted on [ScienceAlert] August 22, 2018 at 03:05AM. All credit to both the author VALENTINA RESETARITS and ScienceAlert | ESIST.T>G>S Recommended Articles Of The Day.

 

 

 

We may finally know why marijuana helps people with chronic gut problems

Your daily selection of the latest science news!

According to Popular Science (This article and its images were originally posted on Popular Science August 13, 2018 at 06:22PM.)

As John Mayer tells us (and tells us, and tells us), your body is a wonderland. When it comes to microbial life, this holds especially true for your gut. There, hundreds of residential species eat, breed, and excrete waste. Somehow, your intestines manage to thrive with this zoo inside them—for the most part. In some cases things aren’t so wonderful: your gut starts attacking itself in an autoimmune response that’s bad for microbes and host alike.

People with this condition, known as inflammatory bowel diseases like Crohn’s disease or ulcerative colitis, face a chronic problem. Current treatment options are laden with side effects and require constant tweaking to remain effective. Some of those people have turned to marijuana for treatment—but their stories about how it has helped them have remained just that, stories, until now. A new study from University of Massachusetts and University of Bath researchers is the first to demonstrate the physical process by which cannabis affects IBD, opening up the possibility of creating new drugs to treat these chronic ailments.

Although numerous IBD patients use cannabis products to help treat their illness, and the phenomena has been subject to some medical research, nobody knew exactly how the medically active parts of marijuana (known as cannabinoids) had an anti-inflammatory effect on irritated bowels before this study. Ironically, however, the researchers weren’t even looking for this precise answer; they just happened upon it in the course of trying to understand how the healthy intestine regulates itself.

In the gut, a thin layer of epithelial cells mediates between our bodies and the microbial “zoo” living within. Beth McCormick of the University of Massachusetts has been studying the role these cells play in regulating the gut microbiome for well over a decade, and the starting point for this current research was her prior discovery of a chemical pathway by which epithelial cells help neutrophils, a kind of white blood cell, to cross into the gut and eat up some of the microbes. But that was clearly only half of the answer. In order to produce balance, something else had to stop too many neutrophils from getting in and killing peaceful microbes and even the gut itself—leading to IBD.

The answer, reported in the new study out Monday in the Journal of Clinical Investigation, is a different pathway, also in the epithelial cells of the gut lining. That chemical pathway produces substances that prevent neutrophils from getting through the epithelial cells and into the gut. And it turns out those substances, in mice at least, are endocannabinoids. These fatty substances bind to the same chemical receptors as the cannabinoids found in, well, cannabis. Patients missing this secondary pathway “were more likely to develop ulcerative colitis,” McCormick says.

Although the current research is in mice, it points to a possible result in humans as well. It would help explain why cannabinoids seem to provide relief for people with IBD, because they perform basically the same regulatory function as the endocannabinoids would if the body were producing them itself. More research, of course, is needed, but McCormick says it opens up the possibility of creating new IBD treatments that work on the new pathway—including, perhaps, therapeutic agents extracted from marijuana.

And that’s not all, says Vanderbilt University gastroenterologist Richard Peek, who wasn’t involved in the new study. McCormick’s findings “may not just be specific to the intestine,” Peek says. Epithelial cells are found on the surfaces of organs throughout the body, so this mechanism of action may exist in other systems as well, he says. That would change our understanding of autoimmune responses elsewhere in the body, too.

This is good news for the 1.6 million Americans who currently have IBD. But given how common a treatment cannabis is for IBD, some might ask why researchers didn’t look for its mechanism of action in the gut before. That’s partially because cannabis research tends to be politicized, says Peek. He thinks that this discovery may open up new possibilities for the legalization of medical marijuana. For McCormick, their “unbiased approach” was the key to finding this result: they weren’t looking to explain cannabis’s mechanism of action, they just found it. “Sometimes, as they say in the field, the blind squirrel finds the nut,” she says.

 

Continue reading… | Stay even more current with our live science feed.

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com.

To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.
__

This article and its images were originally posted on [Popular Science] August 13, 2018 at 06:22PM. All credit to both the author Kat Eschner and Popular Science | ESIST.T>G>S Recommended Articles Of The Day.

 

 

 

Human Trials Show a 30-Year-Old Heart Disease Drug Could Help Treat Type 1 Diabetes

Your daily selection of the latest science news!

According to ScienceAlert (This article and its images were originally posted on ScienceAlert July 11, 2018 at 03:59AM.)

It’s different from all other treatments.

Finger pricks and daily insulin injections are currently the leading regimen for those with type 1 diabetes, a condition in which the body’s insulin producing cells beta cells are destroyed. And it’s not foolproof.

 

Patients can often face risks over overcorrecting their blood sugar levels, which can potentially lead to hypoglycemia – low blood sugar – and coma.

Insulin is responsible for regulating the amount of sugar in the blood, and dysfunctions with it can cause diabetes.

There are two types of diabetes, type 2 diabetes, in which the body becomes insulin resistant and can’t effectively use it, and type 1 diabetes, in which the immune system destroys large portions of the beta cells responsible for making insulin in the pancreas.

In 2015, the Centers for Disease Control and Prevention reported that over 30 million people in the US had diagnosed diabetes, and about 5 percent of them had type 1 diabetes.

Scientists sought to remedy this by repurposing an old drug to do new tricks.

A new study published in Nature Medicine found that verapamil, a drug used to treat high blood pressure, could also be effective at stabilizing blood sugar levels in patients with type 1 diabetes by improving beta cells survival and function.

Dr. Anath Shalev, an author of the study and a professor of Endocrinology, Diabetes & Metabolism at the University of Alabama-Birmingham, said they found previously that an elevation of a key protein called TXNIP in response to increased calcium ion flow into beta cells was a key factor that was present in both type 1 and type 2 diabetes.

Verapamil, which blocks calcium channel activity, was also shown to reduce TXNIP levels, stopping the loss of beta cells in patients with type 1 diabetes.

“This is the first indication that we have of something in hand now that acts very differently from any currently available diabetes treatment, and allows us to improve the patient’s own insulin producing beta cell function,” said Shalev.

“This is the only one that targets this process because so far, most of the treatments are designed to replace the insulin or really squeeze the cells to secrete insulin.”

A clinical trial conducted in 24 adult patients who had developed type 1 diabetes in the past three months showed that if verapamil was taken alongside insulin, patients required less insulin daily, had fewer episodes of hypoglycemia, and maintained good blood sugar control.

Verapamil has been on the market for over 30 years, and according to Shalev, it’s been very well tolerated and has little to no side effects.

Shalev said that since the drug will be used off label, meaning that it will have to be used to treat conditions others than it’s intended for, doctors and patients with type 1 will have to discuss whether it makes sense for them to include the new drug into their treatment plans.

Shalev said that although verapamil is only FDA approved for lowering blood pressure, it is inexpensive and widely available to the public.

According to goodRx, a 30 capsule of 240 microgram pills will cost around US$26. Verapamil should still be used with insulin, but it will require less insulin.

There has been past studies showing that the drug might improve conditions of patients with type 2 diabetes as well, Shalev said.

Moving forward, Shalev and her team want to expand the study to include more patients, especially younger children.

Continue reading…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and its images were originally posted on [ScienceAlert] July 11, 2018 at 03:59AM. All credit to both the author CHARLOTTE HU, BUSINESS INSIDER and ScienceAlert | ESIST.T>G>S Recommended Articles Of The Day.

 

 

Carbon nanotubes used to develop clothing that can double as batteries

Your daily selection of the latest science news!

According to Latest Science News — ScienceDaily (This article and its images were originally posted on Latest Science News — ScienceDaily July 10, 2018 at 08:02PM.)

Engineers with the University of Cincinnati are leveraging a partnership with Wright-Patterson Air Force Base to create clothing that can charge your cell phone.

Move over, Iron Man.

What makes this possible are the unique properties of carbon nanotubes: a large surface area that is strong, conductive and heat-resistant.

UC’s College of Engineering and Applied Science has a five-year agreement with the Air Force Research Laboratory to conduct research that can enhance military technology applications.

UC professor Vesselin Shanov co-directs UC’s Nanoworld Laboratories with research partner and UC professor Mark Schulz. Together, they harness their expertise in electrical, chemical and mechanical engineering to craft “smart” materials that can power electronics.

“The major challenge is translating these beautiful properties to take advantage of their strength, conductivity and heat resistance,” Shanov said.

Schulz said manufacturing is at the cusp of a carbon renaissance. Carbon nanotubes will replace copper wire in cars and planes to reduce weight and improve fuel efficiency. Carbon will filter our water and tell us more about our lives and bodies through new biometric sensors.

Carbon will replace polyester and other synthetic fibers. And since carbon nanotubes are the blackest objects found on Earth, absorbing 99.9 percent of all visible light, you might say carbon is the new black.

“In the past, metals dominated manufacturing goods,” Schulz said. “But I think carbon is going to replace metals in a lot of applications.

“There’s going to be a new carbon era — a carbon revolution,” Schulz said.

UC’s Nanoworld Lab directs the collective work of 30 graduate and undergraduate students.

One of them, UC research associate Sathya Narayan Kanakaraj, co-authored a study examining ways to improve the tensile strength of dry-spun carbon nanotube fiber. His results were published in June in the journal Materials Research Success.

Graduate student Mark Haase, spent the past year exploring applications for carbon nanotubes at the Air Force Research Lab of Wright-Patterson. Through the partnership, UC students use the Air Force Lab’s sophisticated equipment, including X-ray computer tomography, to analyze samples. Haase has been using the Air Force equipment to help his classmates with their projects as well.

“This pushes us to work in groups and to specialize. These are the same dynamics we see in corporate research and industry,” Haase said. “Engineering is a group activity these days so we can take advantage of that.”

UC researchers “grow” nanotubes on quarter-sized silicon wafers under heat in a vacuum chamber through a process called chemical vapor deposition.

“Each particle has a nucleation point. Colloquially, we can call it a seed,” Haase said.

“Our carbon-containing gas is introduced into the reactor. When the carbon gas interacts with our ‘seed,’ it breaks down and re-forms on the surface. We let it grow until it reaches the size we want,” he said.

Researchers can use almost any carbon, from alcohol to methane.

“I remember one group showed off by using Girl Scout cookies. If it contains carbon, you can turn it into a nanotube,” Haase said.

UC’s Nanoworld Lab set a world record in 2007 by growing a nanotube that stretched nearly 2 centimeters, the longest carbon nanotube array produced in a lab at the time. Today’s labs can create nanotubes that are many times longer.

UC researchers stretch the little fibrous square over an industrial spool in the lab. Suddenly, this tiny sheet of carbon becomes a spun thread that resembles spider’s silk that can be woven into textiles.

“It’s exactly like a textile,” Shanov said. “We can assemble them like a machine thread and use them in applications ranging from sensors to track heavy metals in water or energy storage devices, including super capacitors and batteries.”

For the military, this could mean replacing heavy batteries that charge the growing number of electronics that make up a soldier’s loadout: lights, night-vision and communications gear.

“As much as one-third of the weight they carry is just batteries to power all of their equipment,” Haase said. “So even if we can shave a little off that, it’s a big advantage for them in the field.”

Medical researchers are investigating how carbon nanotubes can help deliver targeted doses of medicine.

“On the outside, you can add a protein molecule. Cells will read that and say, ‘I want to eat that.’ So we can deliver medicine to support healthy cells, to restore sick cells or even to kill cancer cells,” Haase said.

But first researchers want to make sure that carbon nanotubes are nontoxic.

“That’s why they’ve been moving slowly,” Haase said. “Research has found that in high or acute exposure, carbon nanotubes can cause lung damage similar to asbestos. The last thing we want to do is cure one cancer only to find it gives you a different one.”

Preliminary results have been promising.

Don’t look for carbon nanotube fashions on Parisian catwalks anytime soon. The costs are too prohibitive.

“We’re working with clients who care more about performance than cost. But once we perfect synthesis, scale goes up considerably and costs should drop accordingly,” Haase said. “Then we’ll see carbon nanotubes spread to many, many more applications.”

For now, UC’s lab can produce about 50 yards of carbon nanotube thread at a time for its research.

“Most large-scale textile machines need miles of thread,” Haase said. “We’ll get there.”

Until then, mass production remains one of the bigger unresolved problems for carbon nanotube technology, said Benji Maruyama, who leads the Materials and Manufacturing Directorate at the Air Force Research Laboratory. “There is still a lot of work to be done in scaling up the process. Pulling a carbon nanotube fiber off a silicon disk is good for lab-scale research but not for making an airplane wing or flight suit,” Maruyama said.

“The only thing holding us back is cracking the code on making carbon nanotubes at scale,” he said.

Maruyama is trying to solve that problem with a series of experiments he is conducting using an autonomous research robot called ARES. The robot designs and conducts experiments with carbon nanotubes, analyzes the results and then uses that data and artificial intelligence to redefine parameters for the next experiment. In this way, it can conduct 100 times as many experiments in the same time as human researchers, he said.

“The big advantage of carbon nanotubes is there’s no shortage of materials. It just requires a metal catalyst — we use iron and nickel — and carbon. It’s not scarce,” Maruyama said. “So when we’re talking about making millions of tons per year of carbon nanotubes, we’re not making millions of tons of something rare.”

The ultimate goal is to convert UC’s academic research into solutions to real problems, Shanov said.

“We have the luxury in academia to explore different applications,” Shanov said. “Not all of them may see the market. But even if 10 percent hit, it would be a great success.”

Continue reading…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and its images were originally posted on [Latest Science News — ScienceDaily] July 10, 2018 at 08:02PM. All credit to both the author and Latest Science News — ScienceDaily | ESIST.T>G>S Recommended Articles  Of The Day.

 

 

 

Marijuana drug wins FDA approval—a first that may change federal regulations

Your daily selection of the latest science news!

According to Science – Ars Technica (This article and its images were originally posted on Science – Ars Technica June 25, 2018 at 04:41PM.)

(cover Image) Enlarge /

Marijuana now has an accepted medical use.

The US Food and Drug Administration announced today, Monday June 25, the approval of the country’s first marijuana-based prescription medication. The drug is called Epidiolex and is a plant-derived oral solution of cannabidiol (CBD)—a chemical component of marijuana that does not cause intoxication or a euphoric “high.” The FDA approved it for use in patients aged two and older who suffer from rare and severe forms of epilepsies known as Lennox-Gastaut syndrome and Dravet syndrome, which can develop early in childhood. Epidiolex’s approval also marks the first time the FDA has approved a drug to treat Dravet syndrome.

With the historic approval, the London-based company behind the drug, GW Pharmaceuticals plc, is expecting another consequential decision in the coming weeks: getting the US Drug Enforcement Administration to reclassify CBD. The move could open the doors to other marijuana-derived medications as well as ease heavy restrictions on marijuana-related research.

Currently, CBD—as with other marijuana components—is classified as a Schedule I drug by the DEA. Schedule I drugs include heroin and LSD as well as marijuana. They’re defined as substances with high abuse potential and “no currently accepted medical use.” As such, Schedule I drugs are strictly regulated, and use of them—including medical use—is against federal law. GW won’t be able to market Epidiolex until the DEA reclassifies CBD.

But the agency is expected to do just that. The FDA noted in its announcement today that it informs and advises the DEA about scheduled substances. In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that “CBD has a negligible abuse potential.”

The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.

In a statement, GW CEO Justin Gover said:

Today’s approval of Epidiolex is a historic milestone, offering patients and their families the first and only FDA-approved CBD medicine to treat two severe, childhood-onset epilepsies… These patients deserve and will soon have access to a cannabinoid medicine that has been thoroughly studied in clinical trials, manufactured to assure quality and consistency, and available by prescription under a physician’s care.

Patients, parents of children suffering from severe epilepsy, and some researchers have long suspected CBD’s potential to treat the devastating seizure disorders. In some cases, patients have moved to states that have legalized medical marijuana in order to have access to the drug. But CBD products available in retail stores can have unreliable concentrations or poor quality controls. A study at the end of last year found that nearly 70 percent of CBD products sold online were mislabeled.

“Controlled clinical trials testing the safety and efficacy of a drug, along with careful review through the FDA’s drug approval process, is the most appropriate way to bring marijuana-derived treatments to patients,” FDA Commissioner Scott Gottlieb, said in a statement today.

He went on:

We’ll continue to support rigorous scientific research on the potential medical uses of marijuana-derived products and work with product developers who are interested in bringing patients safe and effective, high-quality products. But, at the same time, we are prepared to take action when we see the illegal marketing of CBD-containing products with serious, unproven medical claims. Marketing unapproved products, with uncertain dosages and formulations, can keep patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.

Today’s approval “serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. And the FDA is committed to this kind of careful scientific research and drug development,” Gottlieb concluded.

In making the determination to approve Epidiolex, the FDA reviewed data from three high-quality clinical trials showing CBD reduced seizure frequency over placebo in more than 500 patients with one of the two intractable and debilitating forms of epilepsy.

The FDA noted that the most common side effects from Epidiolex were sleepiness, sedation and lethargy, elevated liver enzymes, decreased appetite, diarrhea, rash, fatigue, malaise and weakness, insomnia, sleep disorder and poor quality sleep, and infections.

Continue reading…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and its images were originally posted on [Science – Ars Technica] June 25, 2018 at 04:41PM. All credit to both the author   and Science – Ars Technica | ESIST.T>G>S Recommended Articles Of The Day.

 

 

 

We Have The Best Evidence Yet That Psychedelic Drugs Can Repair Broken Neural Networks

Your daily selection of the latest science news!

According to ScienceAlert (This article and its images were originally posted on ScienceAlert June 14, 2018 at 03:29AM.)

Rewiring the brain in a good way.

Could psychedelic drugs one day play a part in the treatment of mental health conditions? The idea is getting less and less far-fetched, after scientists successfully used drugs including MDMA and LSD to repair neurons in animal tests and cultured cells.

In small microdoses tested on rats, flies, and zebrafish, the substances sparked new growth in neurites, the bridges between neurons that enable internal communications.

With previous research suggesting that neurites in the prefrontal cortex can retract and shrivel when conditions like depression take hold, being able to reverse the process could open up a crucial new avenue for finding effective treatments.

“These are some of the most powerful compounds known to affect brain function,” says senior researcher David E. Olson, from the University of California, Davis. “It’s very obvious to me that we should understand how they work.”

The new study was partly prompted by the increasingly encouraging research that shows ketamine as a way to counteract depression. The drug has been shown to ease suicidal thoughts in hours, and the scientists behind the latest research were keen to see if other hallucinogens might have similar effects on the brain.

They worked through a series of tests in both cultured cells and living animals, covering a variety of mind-altering drugs and different doses in rats, Drosophila (fruit flies), and zebrafish.

While the results varied across tests, across the study as a whole the psychedelics were shown to increase the number of dendrites, or branches between cells, as well as increasing the density of dendritic spines and synapses. These structures all play important roles in the brain’s communication channels.

Even better, in some cases the ‘rewiring’ of the brain lasted longer than the effects of the drugs would normally be expected to.

drugs brain 2The effects of drugs and one control (VEH) on neurons. (Ly et al., CC BY-ND)

“People have long assumed that psychedelics are capable of altering neuronal structure, but this is the first study that clearly and unambiguously supports that hypothesis,” says Olson.

“What is really exciting is that psychedelics seem to mirror the effects produced by ketamine.”

No human cells were included in the tests, but the fact that neurons from multiple species were put under the microscope, and that the team was able to explain the genetic pathway of the mechanism both suggest this might work on human brains as well.

That’s still some way off, but the researchers are planning to investigate whether these psychedelic drugs could be used to improve the plasticity of the brain – its ability to repair itself – without the associated hallucinations or other side effects.

This is going to need closer examination of how these substances affect the brain, and in particular which biological pathways they switch on, and which proteins they produce.

Before we can create compounds suitable for treatment, the researchers say, we need to make sure they’re not having adverse effects on neural networks as well as positive ones.

Another unknown is how psychedelic drugs like these might work on older brains.

“Our work demonstrates that there are a number of distinct chemical scaffolds capable of promoting plasticity like ketamine,” says Olson, adding that this could help us develop safe and effective alternatives.

Continue reading…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and its images were originally posted on [ScienceAlert] June 14, 2018 at 03:29AM. All credit to both the author DAVID NIELD and ScienceAlert | ESIST.T>G>S Recommended Articles Of The Day.

 

 

 

 

 

 

Scientists develop material that could regenerate dental enamel

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories

Cover Image: Close-up of the enamel-like material. Credit: Alvaro Mata

Researchers at Queen Mary University of London have developed a new way to grow mineralised materials which could regenerate hard tissues such as dental enamel and bone.

Enamel, located on the outer part of our teeth, is the hardest in the body and enables our teeth to function for a large part of our lifetime despite biting forces, exposure to acidic foods and drinks and extreme temperatures. This remarkable performance results from its highly organised structure.

However, unlike other tissues of the body, cannot regenerate once it is lost, which can lead to pain and tooth loss. These problems affect more than 50 per cent of the world’s population and so finding ways to recreate enamel has long been a major need in dentistry.

The study, published in Nature Communications, shows that this new approach can create materials with remarkable precision and order that look and behave like .

The materials could be used for a wide variety of dental complications such as the prevention and treatment of tooth decay or tooth sensitivity—also known as dentin hypersensitivity.

Dr. Sherif Elsharkawy, a dentist and first author of the study from Queen Mary’s School of Engineering and Materials Science, said: “This is exciting because the simplicity and versatility of the mineralisation platform opens up opportunities to treat and regenerate dental tissues. For example, we could develop acid resistant bandages that can infiltrate, mineralise, and shield exposed dentinal tubules of human teeth for the treatment of dentin hypersensitivity.”

Scientists develop material that could regenerate dental enamel

Close-up of the enamel-like material. Credit: Alvaro Mata

The mechanism that has been developed is based on a specific protein material that is able to trigger and guide the growth of apatite nanocrystals at multiple scales—similarly to how these crystals grow when dental enamel develops in our body. This structural organisation is critical for the outstanding physical properties exhibited by natural dental enamel.

Lead author Professor Alvaro Mata, from Queen Mary’s School of Engineering and Materials Science, said: “A major goal in is to learn from nature to develop useful materials based on the precise control of molecular building-blocks. The key discovery has been the possibility to exploit disordered proteins to control and guide the process of mineralisation at multiple scales. Through this, we have developed a technique to easily grow synthetic materials that emulate such hierarchically organised architecture over large areas and with the capacity to tune their properties.”

https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/hires/2018/32-scientistsde.jpg

Similarity of structure between the enamel-like material and dental enamel. Credit: Alvaro Mata

Enabling control of the mineralisation process opens the possibility to create with properties that mimic different hard tissues beyond enamel such as bone and dentin. As such, the work has the potential to be used in a variety of applications in regenerative medicine. In addition, the study also provides insights into the role of protein disorder in human physiology and pathology.

Continue reading…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and images were originally posted on [Phys.org – latest science and technology news stories] June 1, 2018 at 05:03AM. Credit to Author and Phys.org – latest science and technology news stories | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

 

International Natural Product Sciences Taskforce (INPST) 2018 Science Communication Award

Your daily selection of the latest science news!

According to International Natural Product Sciences Taskforce (INPST)

Rules for participation

  1. The INPST 2018 Science Communication Award will be given in Gold (2000 USD), Silver (1000 USD), and Bronze (500 USD) to the authors of the three best blog posts that will be published on the INPST website in 2018.

 

  1. Each blog post for participation in the INPST 2018 Science Communication Award needs to have a minimum of 1000 words and at least one image (photo, scheme, or other graphical representation), and needs to be send as a Word file to marc.diederich@me.com (the submission deadline is December 31, 2018). Example of the needed submission format can be viewed here.

 

  1. The submitted blog posts need to be focused on a life sciences-related topic, and to be written in easily understandable (layman’s) terms. Participation with more than one blog posts is allowed. Blogs with more than one authors are allowed (if a blog post with several authors is the winner, the award will be divided to equal parts among the participating authors). Example of a published blog can be viewed here.

 

  1. The winners will be selected based on the quality of the writing and on the provoked public interest (e.g., reflected in parameters such as the number of page views and the number of sharing on the social media). The winners will be announced in March 2019.

 

  1. Why participating in the INPST 2018 Science Communication Award contest? In addition to the monetary Awards, each of the three winners will be honored with a Certificate (in Gold/Silver/Bronze) issued by the distinguished Evaluation Committee. Each blog post published on the INPST website will confer an exceptional scientific and public visibility to both each participating author and to the covered topic (which could be a great chance to promote a scientific topic or research of particular personal interest).

 

Keywords: science communication, blogging, science writing awards, blogger contest, science communication awards, blogs, bloggers, blogging competition, science writing contest.

 

Evaluation Committee of the INPST 2018 Science Communication Award: Atanas G. Atanasov, Bernd L. Fiebich, Ge LinMarc Diederich (Chair of the Committee), Michael Heinrich, Oliver Grundmann, Rachel Mata, and Volkmar Weissig.

 

The INPST 2018 Science Communication Award is sponsored by Envision Biotechnology.

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and images were originally posted on [International Natural Product Sciences Taskforce (INPST)] May 2, 2018 at 04:16AM. Credit to Author and International Natural Product Sciences Taskforce (INPST) | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

A Chemist Shines Light on a Surprising Prime Number Pattern

Your daily selection of the latest science news!

According to Quanta Magazine

About a year ago, the theoretical chemist Salvatore Torquato met with the number theorist Matthew de Courcy-Ireland to explain that he had done something highly unorthodox with prime numbers, those positive integers that are divisible only by 1 and themselves.

A professor of chemistry at Princeton University, Torquato normally studies patterns in the structure of physical systems, such as the arrangement of particles in crystals, colloids and even, in one of his better-known results, a pack of M&Ms. In his field, a standard way to deduce structure is to diffract X-rays off things. When hit with X-rays, disorderly molecules in liquids or glass scatter them every which way, creating no discernible pattern. But the symmetrically arranged atoms in a crystal reflect light waves in sync, producing periodic bright spots where reflected waves constructively interfere. The spacing of these bright spots, known as “Bragg peaks” after the father-and-son crystallographers who pioneered diffraction in the 1910s, reveals the organization of the scattering objects.

Torquato told de Courcy-Ireland, a final-year graduate student at Princeton who had been recommended by another mathematician, that a year before, on a hunch, he had performed diffraction on sequences of prime numbers. Hoping to highlight the elusive order in the distribution of the primes, he and his student Ge Zhang had modeled them as a one-dimensional sequence of particles — essentially, little spheres that can scatter light. In computer experiments, they bounced light off long prime sequences, such as the million-or-so primes starting from 10,000,000,019. (They found that this “Goldilocks interval” contains enough primes to produce a strong signal without their getting too sparse to reveal an interference pattern.)

It wasn’t clear what kind of pattern would emerge or if there would be one at all. Primes, the indivisible building blocks of all natural numbers, skitter erratically up the number line like the bounces of a skipping rock, stirring up deep questions in their wake. “They are in many ways pretty hard to tell apart from a random sequence of numbers,” de Courcy-Ireland said. Although mathematicians have uncovered many rules over the centuries about the primes’ spacings, “it’s very difficult to find any clear pattern, so we just think of them as ‘something like random.’”

But in three new papers — one by Torquato, Zhang and the computational chemist Fausto Martelli that was published in the Journal of Physics A in February, and two others co-authored with de Courcy-Ireland that have not yet been peer-reviewed — the researchers report that the primes, like crystals and unlike liquids, produce a diffraction pattern.

“What’s beautiful about this is it gives us a crystallographer’s view of what the primes look like,” said Henry Cohn, a mathematician at Microsoft Research New England and the Massachusetts Institute of Technology.

The resulting pattern of Bragg peaks is not quite like anything seen before, implying that the primes, as a physical system, “are a completely new category of structures,” Torquato said. The Princeton researchers have dubbed the fractal-like pattern “effective limit-periodicity.”

It consists of a periodic sequence of bright peaks, which reflect the most common spacings of primes: All of them (except 2) are at odd-integer positions on the number line, multiples of two apart. Those brightest bright peaks are interspersed at regular intervals with less bright peaks, reflecting primes that are separated by multiples of six on the number line. These have dimmer peaks between them corresponding to farther-apart pairs of primes, and so on in an infinitely dense nesting of Bragg peaks.

Dense Bragg peaks have been seen before, in the diffraction patterns of quasicrystals, those strange materials discovered in the 1980s with symmetric but nonrepeating atomic arrangements. In the primes’ case, though, distances between peaks are fractions of one another, unlike quasicrystals’ irrationally spaced Bragg peaks. “The primes are actually suggesting a completely different state of particle positions that are like quasicrystals but are not like quasicrystals,” Torquato said.

According to numerous number theorists interviewed, there’s no reason to expect the Princeton team’s findings to trigger advances in number theory. Most of the relevant mathematics has been seen before in other guises. Indeed, when Torquato showed his plots and formulas to de Courcy-Ireland last spring (at the suggestion of Cohn), the young mathematician quickly saw that the prime diffraction pattern “can be explained in terms of almost universally accepted conjectures in number theory.”

It was the first of many meetings between the two at the Institute for Advanced Study in Princeton, N.J., where Torquato was spending a sabbatical. The chemist told de Courcy-Ireland that he could use his formula to predict the frequency of “twin primes,” which are pairs of primes separated by two, like 17 and 19. The mathematician replied that Torquato could in fact predict all other separations as well. The formula for the Bragg peaks was mathematically equivalent to the Hardy-Littlewood k-tuple conjecture, a powerful statement made by the English mathematicians Godfrey Hardy and John Littlewood in 1923 about which “constellations” of primes can exist. One rule forbids three consecutive odd-numbered primes after {3, 5, 7}, since one in the set will always be divisible by three, as in {7, 9, 11}. This rule illustrates why the second-brightest peaks in the primes’ diffraction pattern come from pairs of primes separated by six, rather than four.

Hardy and Littlewood’s conjecture further specified how often all the allowed prime constellations will occur along the number line. Even the simplest case of Hardy-Littlewood, the “twin primes conjecture,” although it has seen a burst of modern progress, remains unproved. Because prime diffraction essentially reformulates it, experts say it’s highly unlikely to lead to a proof of Hardy-Littlewood, or for that matter the famous Riemann hypothesis, an 1859 formula linking the primes’ distribution to the “critical zeros” of the Riemann zeta function.

The findings resonate, however, in a relatively young research area called “aperiodic order,” essentially the study of nonrepeating patterns, which lies at the intersection of crystallography, dynamical systems, harmonic analysis and discrete geometry, and grew after the discovery of quasicrystals. “Techniques that were originally developed for understanding crystals … became vastly diversified with the discovery of quasicrystals,” said Marjorie Senechal, a mathematical crystallographer at Smith College. “People began to realize they suddenly had to understand much, much more than just the simple straightforward periodic diffraction,” she said, “and this has become a whole field, aperiodic order. Uniting this with number theory is just extremely exciting.”

The primes’ pattern resembles a kind of aperiodic order known since at least the 1950s called limit periodicity, “while adding a surprising twist,” Cohn said. In true limit-periodic systems, periodic spacings are nested in an infinite hierarchy, so that within any interval, the system contains parts of patterns that repeat only in a larger interval. An example is the tessellation of a strange, multipronged shape called the Taylor-Socolar tile, discovered by the Australian amateur mathematician Joan Taylor in the 1990s, and analyzed in detail with Joshua Socolar of Duke University in 2010. According to Socolar, computer experiments indicate that limit-periodic phases of matter should be able to form in nature, and calculations suggest such systems might have unusual properties. No one guessed a connection to the primes. They are “effectively” limit periodic — a new kind of order — because the synchronicities in their spacings only hold statistically across the whole system.

For his part, de Courcy-Ireland wants to better understand the “Goldilocks” scale at which effective limit-periodicity emerges in the primes. In 1976, Patrick Gallagher of Columbia University showed that the primes’ spacings look random over short intervals; longer strips are needed for their pattern to emerge. In the new diffraction studies, de Courcy-Ireland and his chemist collaborators analyzed a quantity called an “order metric” that controls the presence of the limit-periodic pattern. “You can identify how long the interval has to be before you start seeing this quantity grow,” he said. He is intrigued that this same interval length also shows up in a different prime number rule called Maier’s theorem. But it’s too soon to tell whether this thread will lead anywhere.

The main advantage of the prime diffraction pattern, said Jonathan Keating of the University of Bristol, is that “it is evocative” and “makes a connection with different ways of thinking.” But the esteemed number theorist Andrew Granville of the University of Montreal called Torquato and company’s work “pretentious” and “just a regurgitation of known ideas.”

Torquato isn’t especially concerned about how his work will be perceived by number theorists. He has found a way to glimpse the pattern of the primes. “I actually think it’s stunning,” he said. “It’s a shock.”

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and images were originally posted on [Quanta Magazine] May 14, 2018 at 01:08PM. Credit to Author and Quanta Magazine | ESIST.T>G>S Recommended Articles Of The Day

Researchers develop new chemistry to make smart drugs smarter

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories

Credit: Georgia State University

A method to activate targeted drugs, or smart drugs, only at the selected site of action, an approach that improves the drug’s therapeutic effect and minimizes side effects, has been developed in a study led by Georgia State University.

Smart drugs, developed to improve the delivery problems of pharmaceutical drugs, are like guided missiles with warheads. They need a targeting molecule to guide pharmaceutical drug molecules to the desired site of action and a trigger to “drop the bomb” or release or activate the drug. In chemistry terms, such smart drugs are conjugates, or links, between a targeting molecule and a drug molecule.

For the most part, the issue of guiding and enriching such to the desired site of action has been resolved. An example is the use of , an emerging class of treatment that targets the delivery of drugs to . However, the issue of when and how to trigger drug release, particularly at a sufficiently high , has been a challenging task.

This study introduces new chemistry and a new concept to allow for “enrichment-triggered activation” of the drug molecule after delivering the smart drug to the desired site of action. The study tested doxorubicin, an , and carbon monoxide, an anti-inflammatory agent, using this delivery method and found the targeted approach effectively treated diseases such as acute liver injury in mice and cancer in cell culture. The researchers linked the active drug to a targeting molecule and then triggered the release of the drug at the desired site of action. The findings are published in the journal Nature Chemistry.

“The general idea is we have a targeting molecule that is conjugated to a payload (pharmaceutical drug molecule), and in between, there’s a linker,” said Dr. Binghe Wang, Regents’ Professor of Chemistry and director of the Center for Diagnostics & Therapeutics at Georgia State, a Georgia Research Alliance Eminent Scholar in Drug Discovery and a Georgia Cancer Coalition Distinguished Cancer Scholar. “The entire purpose of this is to enrich at the site of action. This allows a higher concentration of the drug at the site of action, but minimizes the concentration elsewhere. Essentially, it’s almost like a guided missile.

 

“What we have developed is an approach called enrichment-triggered prodrug activation. Most other chemical approaches rely on some kind of linker chemistry that is not specific enough or there’s a premature release in the general circulation. What we have essentially is a way to control release once the concentration of the drug reaches a certain level. Let’s say you have someone who has prostate cancer. If the drug concentration at the prostate can be a hundredfold higher than the concentration in the bloodstream, chances are you can probably kill all the cancer cells without causing all these side effects.”

In this study, the researchers used this targeted drug delivery approach to administer carbon monoxide to mice and treat acute liver injury. They saw a very potent effect, maybe 10 to 30 times more effective than traditional drug delivery, Wang said. They also tested the anti-cancer drug doxorubicin in cell culture.

They found it’s necessary to use a very stable linker to connect the targeted molecule and active drug so the linker can remain steady as it circulates in the bloodstream. They also needed to trigger a mechanism to release the drug at a desired site of action.

“The linker chemistry design has been very tricky,” Wang said. “There’s a lot of effort that went into it. What we have is something very unique in the sense that we have designed an approach that is not based on typical chemistry. When the (drug) concentration reaches a certain level, then it will automatically start releasing very quickly.”

While this study’s targeted drug delivery approach resembles that of antibody-drug conjugates, which target an antibody (a protein that recognizes foreign substances) on the surface of cancer cells, the current approach doesn’t require having antibodies.

“There are many other molecules that one can use to target different kinds of tissues, diseased organs or sites,” Wang said.

This is also not limited to the cell surface, as used in antibody-drug conjugate delivery, because small are used for targeting and cleaving the from the targeting molecule.

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and images were originally posted on [Phys.org – latest science and technology news stories] May 17, 2018 at 08:03AM. Credit to Author and Phys.org – latest science and technology news stories | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

 

X-ray laser reveals ultrafast dance of liquid water

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories

(Cover Image)
An illustration shows the “blurring” effect caused by water molecules moving during imaging with the X-ray laser. As the laser pulse gets longer, from left to right, the diffraction pattern produced by X-rays hitting the molecules changes (bottom row), reflecting the motion of the water molecules (top row). Experiments at SLAC’s LCLS X-ray laser were able to provide the timescale of the water dynamics by using pulses less than 100 millionths of a billionths of a second long. Credit: Fivos Perakis/Stockholm University

Water’s lack of color, taste and smell make it seem simple – and on a molecular level, it is. However, when many water molecules come together they form a highly complex network of hydrogen bonds. This network is believed to be responsible for many of the peculiar properties of liquid water, but its behavior is not yet fully understood.

Now researchers have probed the movements of molecules in that occur in less than 100 millionths of a billionth of a second, or femtoseconds. An international team led by researchers at Stockholm University carried out the experiments with the Linac Coherent Light Source (LCLS) X-ray laser at the Department of Energy’s SLAC National Accelerator Laboratory. They published their report this week in Nature Communications.

 

The study is the first to “photograph” water molecules on this timescale with a technique called ultrafast X-ray photon correlation spectroscopy, which bounces X-rays pulses off the molecules to produce a series of diffraction patterns. Varying the duration of the X-ray pulses essentially varies the exposure time, and any motion of the water molecules during an exposure will blur the resulting picture. By analyzing the blurring produced by different exposure times, the scientists were able to extract information about the molecular motion.

 

On this timescale, it was assumed that water molecules move randomly due to heat, behaving more like a gas than a liquid. However, the experiments indicate that the network of plays a role even on this ultrafast timescale, coordinating the motions of water molecules in an intricate dance, which becomes even more pronounced when water is “supercooled” below its normal freezing point.

 

“The key to understanding water on a is watching the changes of the hydrogen-bond network, which can play a major role in biological activity and life as we know it,” says Anders Nilsson, a professor at Stockholm University and former professor at SLAC.

 

Adds Stockholm University researcher Fivos Perakis, “It is a brand-new capability to be able to use X-ray lasers to see the motion of in real time. This can open up a whole new field of investigations on these timescales, combined with the unique structural sensitivity of X-rays.”

 

The experimental results were reproduced by computer simulations, which indicate that the coordinated dance of is due to the formation of transient tetrahedral structures.

 

“I have studied the dynamics of liquid and supercooled water for a long time using computer simulations, and it is very exciting to finally be able to directly compare with experiments,” says Gaia Camisasca, a postdoctoral researcher at Stockholm University who performed the computer simulations for this study. “I look forward to seeing the future results that can come out from this technique, which can help improve the current computer models.”

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and images were originally posted on [Phys.org – latest science and technology news stories] May 17, 2018 at 09:03AM. Credit to Author and Phys.org – latest science and technology news stories | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Scientists Say They’ve Transplanted a Memory From One Snail to Another

Your daily selection of the latest science news!

According to ScienceAlert

In a scientific first, researchers claim to have transferred memories between sea snails by injecting RNA from a trained sea snail into one that hasn’t been trained – and observing the trained response in the second snail.

The research wasn’t done to create some sort of mollusc mega-mind, but to help understand the physical basis of memory – and it could aid in both restoring lost memories, and easing the trauma of painful ones.

The researchers, led by biologist David Glanzman of the University of California, Los Angeles, were hoping to understand something called the engram – a physical trace of memory storage.

Recent studies have found that long-term memory can be restored after amnesia with the aid of a priming component. This priming component is still unknown, but the process seems to involve epigenetic modification – something RNA is heavily involved in.

And RNA is also involved in the process of forming long-term memories. This led Glanzman and his team to the possibility that some aspects of long-term memory could be transferred via the molecule.

To test their hypothesis, they trained sea snails. This isn’t as difficult as it sounds – they simply applied a mild, but still unpleasant, electric shock to the tails of a sea snail called Aplysia californica.

Aplysia californicawikimedia largeAplysia californica. (Chad King/NOAA MBNMS/Wikimedia Commons)

The researchers administered five electric shocks to the training group of snails, one every 20 minutes. Then, 24 hours later, the researchers repeated the process.

When researchers tapped the snails afterward, those that had received the shock training contracted their bodies into a defensive posture for an average of around 50 seconds – but the snails that had not been trained only contracted for about one second.

For the next step, RNA was extracted from both the trained and untrained snails. The molecules were then injected into two groups of untrained snails.

What happened next was amazing. The untrained snails that had received RNA from the trained group then responded to taps as though they had been shocked too – contracting defensively for an average of 40 seconds.

Meanwhile, the untrained snails who had received RNA from untrained donors did not exhibit any change in their defensive response.

“It’s as though we transferred the memory,” Glanzman said.

For the next stage of the experiment, the researchers extracted motor neurons and sensory neurons from untrained snails, putting them in petri dishes either separately or in pairs containing one neuron of each type.

They then added RNA from trained and untrained snails to these dishes to observe the effect on the neurons.

They found that adding the RNA of trained snails increased excitability in the sensory neurons – an effect that is also observed when, during training, electric shocks are administered to the snails’ tails.

And, of course, the RNA of untrained snails didn’t have this effect on the sensory neurons.

169951 crop top(Bédécarrats et al., eNeuro, 2018)

It’s currently widely accepted that memory storage is enabled by modifications to the synapses – the structures in the brain that transfer signals between the neurons. But Glanzman believes that they’re actually stored inside the neurons themselves – and his experiment demonstrates this possibility.

“If memories were stored at synapses, there is no way our experiment would have worked,” he said.

Of course, we’ll need further research to confirm this possibility. Firstly, while A. californica is widely used to study neurological processes because of the way their neurons are similar to ours, what we observe in animal models can’t always be applied to humans.

And it’s possible that the RNA is transferring some other process, not necessarily memory.

“It’s interesting, but I don’t think they’ve transferred a memory,” biochemist Tomás Ryan of Trinity College Dublin, who was not involved in the research, told The Guardian.

“This work tells me that maybe the most basic behavioural responses involve some kind of switch in the animal and there is something in the soup that Glanzman extracts that is hitting that switch.”

But if Glanzman is right, his discovery could be a game-changer for those whose lives are negatively impacted by memory.

“I think in the not-too-distant future, we could potentially use RNA to ameliorate the effects of Alzheimer’s disease or post-traumatic stress disorder,” he said.

The research has been published in the journal eNeuro.

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and images were originally posted on [ScienceAlert] May 15, 2018 at 02:40AM. Credit to Author and ScienceAlert | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

An electronic rescue dog

Your daily selection of the latest science news!

According to Latest Science News — ScienceDaily

Trained rescue dogs are still the best disaster workers — their sensitive noses help them to track down people buried by earthquakes or avalanches. Like all living creatures, however, dogs need to take breaks every now and again. They are also often not immediately available in disaster areas, and dog teams have to travel from further afield.

A new measuring device from researchers at ETH Zurich led by Sotiris Pratsinis, Professor of Process Engineering, however, is always ready for use. The scientists had previously developed small and extremely sensitive gas sensors for acetone, ammonia, and isoprene — all metabolic products that we emit in low concentrations via our breath or skin. The researchers have now combined these sensors in a device with two commercial sensors for CO2 and moisture.

Chemical “fingerprint”

As shown by laboratory tests in collaboration with Austrian and Cypriot scientists, this sensor combination can be quite useful when searching for entrapped people. The researchers used a test chamber at the University of Innsbruck’s Institute for Breath Research in Dornbirn as an entrapment simulator. Volunteers each remained in this chamber for two hours.

“The combination of sensors for various chemical compounds is important, because the individual substances could come from sources other than humans. CO2, for example, could come from either a buried person or a fire source,” explains Andreas Güntner, a postdoc in Pratsinis’ group and lead author of the study, published in the journal Analytical Chemistry. The combination of sensors provides the scientists with reliable indicators of the presence of people.

Suitable for inaccessible areas

The researchers also showed that there are differences between the compounds emitted via our breath and skin. “Acetone and isoprene are typical substances that we mostly breathe out. Ammonia, however, is usually emitted through the skin,” explains ETH professor Pratsinis. In the experiments in the entrapment simulator, the participants wore a breathing mask. In the first part of the experiment, the exhaled air was channelled directly out of the chamber; in the second part, it remained inside. This allowed the scientists to create separate breath and skin emission profiles.

The ETH scientists’ gas sensors are the size of a small computer chip. “They are about as sensitive as most ion mobility spectrometers, which cost thousands of Swiss francs and are the size of a suitcase,” says Pratsinis. “Our easy-to-handle sensor combination is by far the smallest and cheapest device that is sufficiently sensitive to detect entrapped people. In a next step, we would like to test it during real conditions, to see whether it is suited for use in searches after earthquakes or avalanches.”

While electronic devices are already in use during searches after earthquakes, these work with microphones and cameras. These only help to locate entrapped people who are capable of making themselves heard or are visible beneath ruins. The ETH scientists’ idea is to complement these resources with the chemical sensors. They are currently looking for industry partners or investors to support the construction of a prototype. Drones and robots could also be equipped with the gas sensors, allowing difficult-to-reach or inaccessible areas to also be searched. Further potential applications could include detecting stowaways and exposing human trafficking.

Story Source:

Materials provided by ETH Zurich. Note: Content may be edited for style and length.

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. To see more posts like this please subscribe to our newsletter by entering your email. By subscribing you’ll receive the top trending news delivered to your inbox.
    __

This article and images were originally posted on [Latest Science News — ScienceDaily] May 16, 2018 at 03:07PM. Credit to Author and Latest Science News — ScienceDaily | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Microwaved plastic increases lithium-sulfur battery life span

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories

Cover Image:
Researchers have discovered that soaking low density plastic in a sulfur-containing solvent, putting it into a microwave and transforming it into a carbon scaffold makes lithium-sulfur batteries last longer and retain elevated capacity. Credit: Purdue University image/Patrick Kim

Purdue engineers have figured out a way to tackle plastic landfills while also improving batteries – by putting ink-free plastic soaked in sulfur-containing solvent into a microwave, and then into batteries as a carbon scaffold.

Lithium-sulfur batteries have been hailed as the next generation of batteries to replace the current variety. Lithium-sulfur batteries are cheaper and more energy-dense than ions, which would be important characteristics in everything from electric vehicles to laptops.

But the knock on to this point is that they don’t last as long, being usable for about 100 charging cycles.

Purdue researchers have found a way to increase the life span in a process that has the added bonus of being a convenient way to recycle . Their process, which was recently published in ACS Applied Materials and Interfaces, shows that putting sulfur-soaked plastic in a microwave, including transparent plastic bags, transforms the material into the ideal substance for increasing the life span of the forthcoming batteries to more than 200 charging-discharging cycles.

“No matter how many times you recycle plastic, that plastic stays on the earth,” said Vilas Pol, associate professor in Purdue’s School of Chemical Engineering. “We’ve been thinking of ways to get rid of it for a long time, and this is a way to at least add value.”

The need to reduce landfills runs parallel to making lithium-sulfur batteries good enough for commercial use.

“Because lithium-sulfur batteries are getting more popular, we want to get a longer life sucked out of them,” Pol said.

Low-density polyethylene plastic, which is used for packaging and comprises a big portion of plastic waste, helps address a long-standing issue with lithium-sulfur batteries – a phenomenon called the polysulfide shuttling effect that limits how long a battery can last between charges.

Lithium-sulfur batteries, as their name suggests, have a lithium and a sulfur. When a current is applied, lithium ions migrate to the sulfur and a chemical reaction takes place to produce . The byproduct of this reaction, polysulfide, tend to cross back over to the lithium side and prevent the migration of lithium ions to sulfur. This decreases the charge capacity of a battery as well as .

 

“The easiest way to block polysulfide is to place a physical barrier between lithium and sulfur,” said Patrick Kim, a Purdue postdoc research associate in chemical engineering.

Previous studies had attempted making this barrier out of biomass, such as banana peels and pistachio shells, because the pores in biomass-derived had the potential to catch polysulfide.

“Every material has its own benefit, but biomass is good to keep and can be used for other purposes,” Pol said. “Waste plastic is really valueless and burdensome material.”

Instead, researchers thought of how plastic might be incorporated into a carbon scaffold to suppress polysulfide shuttling in a battery. Past research had shown that low-density polyethylene plastic yields carbon when combined with sulfonated groups.

The researchers soaked a plastic bag into sulfur-containing solvent and put it in a microwave to cheaply provide the quick boost in temperature needed for transformation into low-density polyethylene. The heat promoted the sulfonation and carbonization of the plastic and induced a higher density of pores for catching polysulfide. The low-density polyethylene plastic could then be made into a carbon scaffold to divide the lithium and sulfur halves of a battery coin cell.

“The plastic-derived carbon from this process includes a sulfonate group with a negative charge, which is also what polysulfide has,” Kim said. Sulfonated low-density polyethylene made into a carbon scaffold, therefore, suppressed polysulfide by having a similar chemical structure.

“This is the first step for improving the capacity retention of the battery,” Pol said. “The next step is fabricating a bigger-sized battery utilizing this concept.”

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. Also subscribe now to receive daily or weekly posts.
    __

This article and images were originally posted on [Phys.org – latest science and technology news stories] May 9, 2018 at 11:03AM. Credit to Author and Phys.org – latest science and technology news stories | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

 

FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help addicted people break the habit

Your daily selection of the latest science news!

According to Medical Xpress

Cover Image:
The green fluorescent ‘dots’ above show where Exendin-4, an FDA-approved drug used to treat diabetes and obesity, ends up in the brain. The drug activates receptors for glucagon-like peptide 1 or GLP-1, a hormone that reduces food intake. The blue and red coloring indicate neurons and astrocytes, respectively. Credit: University of Pennsylvania

Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that’s why it’s so hard to quit using these substances. Moreover, relapse rates hover between 40 and 60 percent, similar to rates for other chronic conditions like hypertension and Type 1 diabetes.

University of Pennsylvania behavioral pharmacologist and neuroscientist Heath Schmidt studies how long-term exposure to drugs such as cocaine, nicotine, and prescription opioids affects the brain and how these changes promote relapse in someone who has kicked the habit. A recent paper, published in the Nature journal Neuropsychopharmacology, investigated a novel treatment for cocaine addiction, something that touches 900,000 people in the United States annually.

“As a basic scientist I’m interested in how the brain functions during periods of abstinence from cocaine and other drugs and how neuro-adaptations in the brain promote relapse back to chronic taking,” he explains. “From the clinicians’ perspective, they’re looking for medications to try to prevent relapse. Our goal as basic scientists is to use animal models of relapse to identify novel medications to treat cocaine addiction.”

Schmidt and colleagues from Penn Nursing and Penn Medicine had hypothesized that the neural mechanisms and neural circuits in the brain that play a role in food-seeking might overlap with those key to drug-taking. Through several experiments, they discovered that drugs that activate receptors for glucagon-like peptide 1 (GLP-1), a hormone that reduces food intake and blood glucose levels, could actually decrease the desire to seek out cocaine. What’s more, there are several FDA-approved medications used to treat diabetes and obesity that already target GLP-1 receptors.

“One of the first questions we had—and we were really just kind of curious—was, does cocaine at all affect circulating levels of metabolic factors like leptin, insulin, GLP-1 that have been shown to regulate food intake?” says Schmidt, whose primary appointment is in Penn’s School of Nursing.

The research team got its answer from a simple experiment with a rat animal model: Blood drawn after 21 days of cocaine intake revealed decreased levels of the GLP-1 hormone. Though the primary cells that synthesize and release this hormone are found in the small intestine, there’s also a source in the brain called the nucleus tractus solitarius.

 

“Knowing all of this got us interested in GLP-1,” Schmidt says. “Does it actually play a role in modulating cocaine-mediated behaviors?”

From there, the research team homed in on GLP-1 receptors and the drugs that activate them, what are known as receptor agonists. To test the efficacy of the medications in question, Schmidt and colleagues used an of relapse with rats. For a three-week period, the rats could press a lever for intravenous infusions of cocaine as frequently as they desired. On average, the animals self-administered 28 infusions of cocaine each day.

The scientists then swapped out the cocaine for saline, leading to a period of withdrawal. Lever-pressing rates dropped significantly.

“At that point, we considered drug-taking to be extinguished,” Schmidt says. “We then reinstated drug-seeking by re-exposing the rats to the drug itself or to cues paired with the drug during the self-administration phase, like a light that comes on when the lever gets pressed.”

Once again rats depressed the lever at high rates, an indication that they were seeking the drug—akin to relapse in a human who is addicted.

The researchers next pretreated the animals with one of the FDA-approved drugs intended for diabetes and obesity treatment, Exendin-4, to determine whether it might reduce or altogether block cocaine-seeking. Results showed a significant decrease in drug-craving and -seeking, both after an acute injection of cocaine and from re-exposure to environmental cues during withdrawal.

“This tells us Exendin-4 can block the effects of cocaine itself but also condition stimuli previously paired with cocaine,” Schmidt notes. “This was really exciting because it’s the first demonstration that the GLP-1 system, and the drugs that target this system, could potentially play an important role in cocaine seeking and relapse. The other really interesting aspect of these studies are the doses.”

GLP-1 receptor agonists are known to cause nausea and vomiting at pretty high rates in diabetic and obese patients who use them, so Schmidt and colleagues wanted to ensure that the reason for a decrease in cocaine-seeking wasn’t from animals being sick. They identified doses that both reduced cocaine-seeking and did not produce adverse effects. A follow-up experiment that infused the GLP-1 agonist directly into the brain replicated the findings. Taken together, these findings indicate that low doses of a GLP-1 receptor agonist can selectively reduce cocaine-seeking without causing nausea.

As a final step, the researchers isolated the brain pathway able to boost GLP-1 signaling, by using a fluorescent dye to track where the drugs actually went in the body after they were administered.

“We’ve shown for the first time that central GLP-1 signaling plays an important role in cocaine-seeking,” Schmidt explains. “We’ve identified systematic and intra-cranial doses of GLP-1 receptor agonists that reduce cocaine-seeking and don’t produce adverse effects, and we think that if you increase GLP-1 signaling in the brain in general, you can reduce cocaine-seeking in rats and, potentially, craving-induced relapse in humans.” To begin testing this, Schmidt’s team is collaborating with researchers at Yale University to screen the efficacy of these drugs in a population of humans addicted to cocaine.

Beyond that, Schmidt says he’s hopeful these results have potential for drugs of abuse beyond cocaine, too. However, he adds, much more research is needed before this can be stated conclusively. “There is a lot we don’t know about the GLP-1 system in the brain,” he says. “What is the exact circuitry in the ? Is this signaling the same as what mediates food intake or is it slightly different? Does cocaine change it in any way? We’re working on that.”

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. Also subscribe now to receive daily or weekly posts.
    __

This article and images were originally posted on [Medical Xpress] April 28, 2018 at 07:31AM. Credit to Author and Medical Xpress | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

There’s a Link Between Cannabis And Psychosis, And We Can’t Ignore It

 

Your daily selection of the latest science news!

According to ScienceAlert

https://www.sciencealert.com/images/2018-04/processed/yoann-boyer-316485-unsplash-weed-psychosis_600.jpg

There has been a recent global rise in “green fever”, with various jurisdictions either decriminalising or legalising cannabis.

But alongside relaxing the rules comes concern about the health implications of cannabis use. We often hear of a link between cannabis use and psychosis. So how strong is the link, and who is at risk?

What is psychosis?

There’s consistent evidence showing a relationship over time between heavy or repeated cannabis use (or those diagnosed with cannabis use disorder) and an experience of psychosis for the first time.

Psychotic disorders are severe mental health conditions. They’re characterised by a “loss of contact with reality”, where the individual loses the ability to distinguish what’s real from what’s not. Psychotic symptoms can include visual hallucinations, hearing voices, or pervasive delusional thinking.

These can often present as a “psychotic episode” – which is a relatively sudden worsening of psychotic symptoms over a short time-frame, frequently resulting in hospitalisation.

The heaviest users of cannabis are around four times as likely to develop schizophrenia (a psychotic disorder that affects a person’s ability to think, feel and behave clearly) than non-users.

Even the “average cannabis user” (for which the definition varies from study to study) is around twice as likely as a non-user to develop a psychotic disorder.

Furthermore, these studies found a causal link between tetrahydrocannabinol (THC – the plant chemical which elicits the “stoned” experience) and psychosis. This means the link is not coincidental, and one has actually caused the other.

Who is at risk?

People with certain gene variants seem to be at higher risk. However our understanding of these factors is still limited, and we’re unable to use genetic information alone to determine if someone will or won’t develop psychosis from cannabis use.

Those with these genetic variants who have also experienced childhood trauma, or have a paranoid personality type, are even more at-risk. So too are adolescents and young adults, who have growing brains and are at an age where schizophrenia is more likely to manifest.

The type of cannabis material being used (or the use of synthetic cannabinoids, known as “spice”) may also increase the risk of psychosis. As mentioned above, this is due to the psychological effects of the chemical THC (one of over 140 cannabinoids found in the plant).

This compound may actually mimic the presentation of psychotic symptoms, including paranoia, sensory alteration, euphoria, and hallucinations.

In laboratory-based research, even healthy people may exhibit increased symptoms of psychosis when given THC compounds, with more severe effects observed in people with schizophrenia.

Many cannabis strains contain high amounts of THC, found in plant varieties such as one called “skunk”. These are popular with consumers due to the “high” it elicits. However with this goes the increased risk of paranoia, anxiety, and psychosis.

But can’t cannabis also be good for mental health?

Ironically, one compound found in cannabis may actually be beneficial in treating psychosis. In contrast to THC, a compound called cannabidiol (CBD) may provide a buffering effect to the potentially psychosis-inducing effects of THC.

This may occur in part due to its ability to partially block the same brain chemical receptor THC binds with. CBD can also inhibit the breakdown of a brain chemical called “anandamide,” which makes us feel happy.

Incidentally, anandamide is also found in chocolate and is aptly named after the Sanskrit word meaning “bliss”.

CBD extracted from cannabis and used in isolation is well-tolerated with minimal psychoactive effects. In other words, it doesn’t make a person feel “high”.

Some studies have found CBD is actually beneficial in improving the symptoms of schizophrenia. But one more recent study showed no difference in the effects of CBD compared to a dummy pill on symptoms of schizophrenia.

Perhaps this means CBD benefits a particular biological sub-type of schizophrenia, but we’d need further study to find out.

Would legalising make a difference?

It’s important to note most studies finding a causal link between cannabis use and psychosis examined the use of illicit cannabis, usually from unknown origins.

This means the levels of THC were unrestricted, and there’s a possibility of synthetic adulterants, chemical residues, heavy metals or other toxins being present due to a lack of quality assurance practices.

In the future, it’s possible that standardised novel “medicinal cannabis” formulations (or isolated compounds) may have negligible effects on psychosis risk.

The ConversationUntil then though, we can safely say given the current weight of evidence, illicit cannabis use can increase the risk of an acute psychotic episode.

And this subsequently may also increase the chances of developing schizophrenia. This is particularly true when high-THC strains (or synthetic versions) are used at high doses in growing adolescent brains.

Read more…

  • Got any news, tips or want to contact us directly? Feel free to email us: esistme@gmail.com. Also don’t forget to subscribe now to receive our posts daily or weekly.
    __

This article and images were originally posted on [ScienceAlert] April 25, 2018 at 06:42AM. Credit to Author and ScienceAlert | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Researchers Find New DNA Structure in Living Human Cells

Your daily selection of the latest science news!

According to Breaking Science News

A team of scientists from the Garvan Institute of Medical Research and the Universities of New South Wales and Sydney has identified a new DNA structure — called the intercalated motif (i-motif) — inside living human cells.

A twisted ‘knot’ of DNA, the i-motif has never before been directly seen inside living cells. Image credit: Zeraati et al, doi: 10.1038/s41557-018-0046-3.

Deep inside the cells in our body lies our DNA. The information in the DNA code — all 6 billion A, C, G and T letters — provides precise instructions for how our bodies are built, and how they work.

The iconic ‘double helix’ shape of DNA has captured the public imagination since 1953, when James Watson and Francis Crick famously uncovered the structure of DNA.

However, it’s now known that short stretches of DNA can exist in other shapes, in the laboratory at least — and scientists suspect that these different shapes might play an important role in how and when the DNA code is ‘read.’

“When most of us think of DNA, we think of the double helix. This research reminds us that totally different DNA structures exist — and could well be important for our cells,” said co-lead author Dr. Daniel Christ, from the Kinghorn Centre for Clinical Genomics at the Garvan Institute of Medical Research and St Vincent’s Clinical School at the University of New South Wales.

“The i-motif is a four-stranded ‘knot’ of DNA,” added co-lead author Dr. Marcel Dinger, also from the Garvan Institute of Medical Research and the University of New South Wales.

“In the knot structure, C letters on the same strand of DNA bind to each other — so this is very different from a double helix, where ‘letters’ on opposite strands recognize each other, and where Cs bind to Gs [guanines].”

Although researchers have seen the i-motif before and have studied it in detail, it has only been witnessed in vitro — that is, under artificial conditions in the laboratory, and not inside cells. In fact, they have debated whether i-motif DNA structures would exist at all inside living things — a question that is resolved by the new findings.

To detect the i-motifs inside cells, Dr. Christ, Dr. Dinger and their colleagues developed a precise new tool — a fragment of an antibody molecule — that could specifically recognize and attach to i-motifs with a very high affinity.

Until now, the lack of an antibody that is specific for i-motifs has severely hampered the understanding of their role.

Crucially, the antibody fragment didn’t detect DNA in helical form, nor did it recognize ‘G-quadruplex structures’ (a structurally similar four-stranded DNA arrangement).

With the new tool, the team uncovered the location of ‘i-motifs’ in a range of human cell lines.

Using fluorescence techniques to pinpoint where the i-motifs were located, the study authors identified numerous spots of green within the nucleus, which indicate the position of i-motifs.

The scientists showed that i-motifs mostly form at a particular point in the cell’s ‘life cycle’ — the late G1 phase, when DNA is being actively ‘read.’

They also showed that i-motifs appear in some promoter regions — areas of DNA that control whether genes are switched on or off — and in telomeres, ‘end sections’ of chromosomes that are important in the aging process.

“We think the coming and going of the i-motifs is a clue to what they do. It seems likely that they are there to help switch genes on or off, and to affect whether a gene is actively read or not,” said study first author Dr. Mahdi Zeraati, also from the Garvan Institute of Medical Research and the University of New South Wales.

“We also think the transient nature of the i-motifs explains why they have been so very difficult to track down in cells until now,” Dr. Christ added.

“It’s exciting to uncover a whole new form of DNA in cells — and these findings will set the stage for a whole new push to understand what this new DNA shape is really for, and whether it will impact on health and disease,” Dr. Dinger said.

The team’s results appear in the journal Nature Chemistry.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Breaking Science News] April 24, 2018 at 03:11PM. Credit to Author and Breaking Science News | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

 

 

Everything you never wanted to know about artificial sweeteners

Your daily selection of the latest science news!

According to Popular Science


There are a lot of myths about artificial sweeteners. The main one is that they’re actually better for you than regular sugar. Low-calorie sweeteners have been around for decades now, and we’re finally at a point where we’ve studied them enough to understand roughly how they work and what effect they have on our bodies.

Despite how long we’ve had diet versions of our favorite soft drinks, though, plenty of people still aren’t clear on the facts. Misunderstandings left over from the early days are still widespread. For example…

Erm… is that whole cancer thing true?

Let’s get this one out of the way. While it is true that some rodent studies found increased rates of certain kinds of cancer, like leukemia, after eating artificial sweeteners, subsequent testing has shown that you don’t need to worry about getting cancer from your diet soda. You’d have to regularly consume astronomical doses of the stuff. On the other hand, we do know that obesity is a major risk factor for many kinds of cancer, so maybe focus on that instead of sucralose.

So I should pick diet soda over regular to lose weight then, right?

We hate to be that guy, but “well, actually…” a lot of the evidence suggests you’d be better off just trying to cut back on the regular soda. It does seem like having fewer calories should help you lose weight, but studies indicate that weight loss isn’t as simple as calories in versus out. You can trick your tastebuds (sort of) into thinking that aspartame or saccharin is the sugar you crave, but your brain isn’t so simple.

More and more evidence is piling up that suggests the diet drink trend is misguided. Or as one 2008 study on obesity and artificial sweeteners asked in its conclusion: “are [artificial sweeteners] fueling—rather than fighting—the very epidemic they were designed to block?”

A few recent studies suggest that consuming fake sugar actually trains your insulin response to store more fat, not less. Basically when you consume real sugar, your tastebuds send an alert to your pancreas that says, “Hey, calories are on the way! Prepare to produce insulin!” The insulin then helps break down the sugars, which either provide immediate energy or go into fat cells for storage. If your body interprets something as sweet when there’s not really sugar on the table, though, it may end up producing that same insulin response. So that diet soda is still prompting your pancreas to store fat, even though you’re not getting to enjoy real sugar—your brain can tell the difference. Artificial sweeteners don’t trigger our reward circuits the same way, so you don’t get the satisfaction of ingesting sugar.

And on top of that, constantly pumping up your insulin response eventually leads it to malfunction. This is essentially what happens in type 2 diabetes, but can occur to a lesser—but still harmful—extent in otherwise healthy people. Eventually your pancreas starts producing too much insulin in response to all food, making you pack on the pounds.

This whole theory is still being tested, but it’s in line with what we observe in people who drink diet beverages: they tend to gain weight. In observational studies you can’t tell whether that’s causative or if it’s just that overweight people tend to drink more diet soda than people at a healthy weight. One clue is that scientists observe what’s known as a dose response. The more artificial sweeteners people consume, the more weight they seem to put on. That suggests it might be the fake sugars themselves that prompt the gain in poundage, not just an association.

Okay, fine. I can totally give this up

There’s some bad news here: it’s hard to quit any kind of sugar, even the artificial stuff. Sugars activate our reward circuits—they give us a hit of feel-good neurochemicals that prompt us to continue craving them. The more sugar you eat, the more you want it.

Since artificial sweeteners don’t satisfy your brain the way real sugar does, though, you don’t sate the craving. You’ll keep hankering after sweet foods and will probably end up eating more calories overall. That adds up to more pounds than you would’ve gained just by eating that cupcake in the first place.

And if you need a more compelling reason, let us all remember the infamous story of the cocaine-addicted rats who preferred sweets over drugs. A 2007 study got a bunch of rats hooked on cocaine and saccharin, then given a choice—cocaine or fake sugar?—most chose the sugar substitute. They were so addicted to saccharin that the researchers wrote they couldn’t give the rats enough cocaine to overcome their desire for a hit of sweetness. The same was true for real sugar.

That’s a powerful addiction, and it shouldn’t be underestimated. You can absolutely quit sugar, real or fake, just like people can absolutely quit cocaine. You just need to take it seriously as an addiction. Don’t think it’ll be easy.

What if I’m just using it to bridge the gap while I quit sugar altogether?

Lots of people switch to diet soda as they’re trying to lose weight, in the hope that the fake stuff will be a satisfactory substitute for real sugar. As we’ve already mentioned, it’s not actually satisfying, and what’s more you’ll probably end up handicapping yourself by trying to trick your brain.

Like people who start exercising, people who drink diet beverages start thinking about how they’re now down on their calorie-count, and whether consciously or subconsciously they often compensate by eating more overall. More calories on average can end up causing more harm to your weight loss goals than the occasional candy bar would have.

You’ll also probably start losing your ability to appreciate more subtle flavors. David Ludwig, a weight-loss specialist at Boston Children’s Hospital, told Harvard Health this about how our tastes can change: “Non-nutritive sweeteners are far more potent than table sugar and high-fructose corn syrup. A miniscule amount produces a sweet taste comparable to that of sugar, without comparable calories. Overstimulation of sugar receptors from frequent use of these hyper-intense sweeteners may limit tolerance for more complex tastes.” That means naturally sweet foods like peaches won’t taste nearly as good, and anything without that hint of sweetness might end up seemingly completely gross.

Ludwig notes too that natural sources of sugar, like fruit, often don’t have the same effect on our insulin responses that candy and cake do. Fiber and other nutrients in fruit help keep your blood sugar levels lower, rather than spiking suddenly, and thus prevents your body from storing all those calories as fat.

So what the heck am I supposed to do when I’m craving sweets!?

Here’s the good news: you can eat real sugar! You should eat real sugar. Just eat it in moderation. Satisfy the craving with a mini candy bar (or heck, even a whole piece of cake). Just try to make your overall eating habits as healthy as possible. Occasional sugar won’t make you pack on the pounds. It’s the constant insulin spikes and misleading artificial sweeteners that get you. Have your cake and eat it too—just don’t eat it every day.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Popular Science] April 18, 2018 at 08:18AM. Credit to Author and Popular Science | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Drug compound shows promise against rheumatoid arthritis

Your daily selection of the latest science news!

According to Medical Xpress

Drug compound shows promise against rheumatoid arthritis
Shown are 3-D CT scans of rat paws. The image on the left shows a normal paw. In the center image, the effects of rheumatoid arthritis are visible at the joint. The image on the right indicates the drug compound CDD-450 reduces this damage. Credit: Mbalaviele lab

Scientists have designed a new drug compound that dials down inflammation, suggesting possible future uses against autoimmune disorders such as rheumatoid arthritis.

The new inhibitor is more selective than other compounds designed to target the same inflammatory pathway, according to new research from Washington University School of Medicine in St. Louis. Such precision, along with other beneficial characteristics of the new inhibitor, may improve upon some of the downsides of current therapies.

The study appears online in the Journal of Experimental Medicine.

A protein called p38 MAPK, when working properly, is responsible for helping tissue remain healthy, but if the protein becomes chronically switched on, it creates collateral damage, attacking the body’s own tissues. Autoimmune disorders such as and psoriatic arthritis can result.

Because the protein drives in many disorders, several drug companies have developed anti-inflammatory compounds that block its signaling. While these compounds have an anti-inflammatory effect for a while, the body recalibrates and inflammation returns after a period of time.

“Because of the protein’s role in inflammation, pharmaceutical companies wanted to block p38 MAPK and developed drugs to do so,” said senior author Gabriel Mbalaviele, associate professor of medicine. “The drugs appeared to do well initially in small clinical trials, but the drugs’ effectiveness collapsed at later time points. Markers of inflammation went down at first, but after two or three weeks, they went back up. We wanted to develop a compound that is more precise, just blocking the portion of the pathway that we now understand drives inflammation and nothing else.”

Rather than blocking the entire pathway, the new compound—called CDD-450—hits just one of several branches a bit downstream of the p38 MAPK protein. Blocking that pathway while allowing the other branches to operate freely may remedy the inflammation recalibration problem.

Studying mice, rats and human cells, the researchers showed that the new compound reduces levels of inflammatory signaling molecules. The scientists further showed that it prevents the destruction of bones and joints in a rat model of rheumatoid arthritis.

“This compound—developed by an independent company called Confluence Discovery Technologies Inc.—is novel because it is not a global inhibitor of the p38 MAPK protein,” said Mbalaviele, who co-founded the company. “It only blocks the p38 MAPK-MK2 downstream pathway—the one that drives inflammation. And more importantly, we showed that it blocks these signals in a rat model of inflammatory disease, preventing the bone loss and joint damage that is characteristic of rheumatoid arthritis.”

Further, the new compound does not have the downsides of some anti-inflammatory drugs currently in use, Mbalaviele said. Some relatively new anti-inflammatory treatments, called biologics, must be injected into the bloodstream, which makes them unpopular with many patients, according to the researchers.

Another downside of biologics involves the immune system. Biologics are made of short sequences. Consequently, the body’s immune system may recognize biologics as foreign and eliminate them, resulting in a buildup of resistance. In contrast, the new inhibitor is a small molecule bearing no resemblance to proteins. CDD-450 is a chemical compound that could be taken by mouth and could avoid an immune response, therefore maintaining its effectiveness, Mbalaviele said.

He and co-authors Shaun R. Selness and Joseph B. Monahan founded Confluence Discovery Technologies in 2010 to boost development of drug as potential new therapies for inflammatory diseases. In late 2017, Confluence was acquired by Aclaris Therapeutics Inc., which is continuing that work. Monahan and several other co-authors of the current study are employees of Confluence. Mbalaviele reports serving as a consultant for Confluence.

“The company is moving toward early clinical trials to test the safety of CDD-450 (now called ATI-450) in people,” Mbalaviele said. “My lab will continue to study these inflammatory pathways so we can develop a better understanding of how these signaling molecules lead to bone destruction and other detrimental effects of autoimmune disease.”

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Medical Xpress] March 28, 2018 at 07:02AM. Credit to Author and Medical Xpress | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

A male birth control pill that dramatically lowers testosterone levels is moving forward into a 3-month trial

Your daily selection of the latest science news!

According to Tech Insider

happy couple

  • A new kind of male birth control pill was recently tested in a month-long trial, and is moving forward into a three-month study — the next step in the FDA approval process.
  • The pill is taken once daily with a meal.
  • Some men who took it gained a few pounds, and some decreased their levels of “good” HDL cholesterol.
  • The experimental pill is at least five to 10 years away from coming to market. 

For decades, men have had only two ways to actively avoid impregnating a partner: wear a condom (which are about 85% effective) or get a vasectomy.

But doctors Stephanie Page from the University of Washington and Christina Wang from UCLA are testing a new drug for men that works a lot like “the pill” for women. They’re hoping the once-daily hormone-suppressing pill might become a new option for preventing unwanted pregnancies.

“Men actually are very interested in contraception,” Page told Business Insider. “Between vasectomy and condoms, they do about 17% of the contracepting in the United States. They just don’t have a lot of choices.”

The experimental drug was recently tested in a one-month trial involving 83 subjects. It’s called dimethandrolone undecanoate, or DMAU, and works by suppressing male body’s natural sex hormone (testosterone). In its current form, the pill lowers a man’s testosterone levels to what they were in boyhood or lower, essentially like a chemical castration.

To balance out the effects of men’s low testosterone levels while taking the drug, the patients were given a synthetic androgen, or male steroid hormone, to help them maintain their “male” characteristics. The artificial hormone is designed to mimic the role testosterone plays in non-sperm-related functions in the body, like sex drive, musculation, and hair growth.

When men stop taking the pill, their natural hormones should have a resurgence, and they’ll be able to impregnate again. It’s similar to the way hormonal birth control works in women.

Page and Wang are readying their drug for a three-month, FDA phase-2 trial that’s set to start next month. The pill looks a bit like a fish oil capsule, and will be tested in men from 18 to 50 years old, with doses ranging from 200 to 400 milligrams a day.

Now that the researchers have seen that their pill can indeed lower men’s testosterone, the longer study will assess how effectively the men’s sperm count is annihilated by those lower testosterone levels.

Why we don’t have a male birth control pill yet

“The pill” for women has been on the market for nearly 60 years. There are several reasons there’s no male equivalent yet: part of the problem has been a lack of support from drug makers, but a more scientific challenge has been the mathematical reality that it’s tougher to exterminate the millions of sperm that come out of men’s bodies than the monthly egg or two that passes through a woman’s reproductive system.

“Women only ovulate 1 or 2 eggs a month,” Page said. “Men on the other hand, are making 1,000 sperm a second. So every time a man ejaculates, there’s 15 to 100 million sperm.”

birth control

Many prior attempts to create male birth control drugs have had problems with side effects too, especially with liver damage. Page and Wang think they’ve fixed that issue in their new pill, but the initial one-month trial did raise concerns about other side effects.

Like a lot of women who take hormonal birth control, some men gained weight on the pill. Some put on a few pounds, some gained none, and one unlucky man gained nearly nine pounds in the one-month study. In general, the men also saw their levels of HDL cholesterol (considered the good kind) drop slightly.

Pharmaceutical companies haven’t bought into male birth control yet

Page said that even in a best case scenario, a male birth control pill for consumers is still between five and 10 years away, since much larger-scale studies need to be done before the FDA would give a seal of approval.

The men’s pill also needs to clear another major hurdle: a pharmaceutical company has to pay to make the drug. That’s something other male birth-control makers have struggled with in the past. Last year, Indian biomedical engineer Sujoy Guha was ready to take injectable birth control gel — in the form of a shot that men could slip into their scrotum — to market. But he couldn’t get any big pharmaceutical companies to back the product, as Bloomberg reported.

We don’t yet know what challenges might arise if men were to use hormonal birth control long-term. But 58 years of hormonal birth control use in women suggest that it can come with serious risks. Taking the pill heightens a woman’s risk of developing breast and cervical cancer, increases her risk of depression, and can cause her blood pressure to rise.

That hasn’t deterred roughly 16% of American women between the ages of 15-44 from taking the tablets every day, as Guttmacher Institute estimates. There’s a reason they’re willing to take on the risks.

“Pregnancy is still a life threatening condition,” Page said. “The risks and the need for women is much greater.”

 

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Tech Insider] March 23, 2018 at 08:38AM. Credit to Author and Tech Insider | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Autism’s social deficits are reversed by an anti-cancer drug

Your daily selection of the latest science news!

According to Latest Science News — ScienceDaily

Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.

The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.

The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.

Profound, prolonged effect

“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.

The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.

In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.

To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.

Epigenetics in ASD

Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.

“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.

She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.

“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”

To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.

Loosening up chromatin

In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.

“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”

But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.

“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.

The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.

“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism.” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Latest Science News — ScienceDaily] March 13, 2018 at 11:16AM. Credit to Author and Latest Science News — ScienceDaily | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

EGaming, the Humble Book Bundle: Mad Scientist is LIVE!

madscientist_books_logo-dark-retina.png

The Humble Book Bundle: Mad Scientist by Make: just launched on Wednesday, March 7 at 11 a.m. Pacific time! We’ve teamed up with Make: for our newest bundle! Get titles like Illustrated Guide to Home Chemistry, Make: High-Power Rockets, and Make: Fire. Plus, this bundle supports Maker Education!

Humble Book Bundle: Mad Scientist by Make:

 


This article and images were originally posted on [ESIST] and sponsored by HUMBLE BUNDLE
+ Got any news, tips or want to contact us directly? Email esistme@gmail.com

ESIST may receive a commission for any purchases made through our affiliate links. All commissions made will be used to support and expand ESIST.Tech

 

 

 

Breaking local symmetry—why water freezes but silica forms a glass

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories

Breaking local symmetry: Why water freezes but silica forms a glass
The origin of SiO2 glass formation revealed by simulations. Credit: 2018 HAJIME TANAKA, INSTITUTE OF INDUSTRIAL SCIENCE, THE UNIVERSITY OF TOKYO

Everyone knows that water freezes at 0 degrees C. Life on Earth would be vastly different if this were not so. However, water’s cousin, silica, exhibits wayward behavior when cooled that has long puzzled scientists.

Unlike water, silica (SiO2) does not freeze easily. When liquid silica cools, its atoms fail to arrange into an ordered crystal. Instead, as temperature decreases, the liquid state survives even far below the nominal freezing temperature. This phenomenon is called supercooling. Eventually, the atoms are simply locked into place wherever they are, preserving the structural disorder of the liquid. The resulting frozen state of matter—mechanically solid, but microscopically liquid-like—is a glass.

 

Silica’s preference for glass formation has major consequences, since it is among the most abundant compounds on Earth. In some ways, silica and water are alike—they have similar coordination geometries with tetrahedral symmetry, and both display an unusual tendency to become less dense below a certain temperature on cooling, but more fluid upon pressurizing. They even show analogous crystal structures when silica can be coaxed into freezing.

 

Recently, researchers at The University of Tokyo’s Institute of Industrial Science uncovered vital clues as to why water and silica diverge so starkly when they become cold. In a study published in PNAS, their simulations revealed the influence of the local symmetric arrangement of atoms in the liquid state on crystallization. It turns out that the atoms arrange properly in water while not in silica.

 

When liquids cool, order emerges from randomness, as the atoms assemble into patterns. From the viewpoint of any individual atom, a series of concentric shells appear as its neighbors gather round. In both water and silica, the first shell (around each O or Si atom, respectively) is tetrahedral in shape—a case of orientational ordering, or “symmetry breaking.” The key difference is the second shell structure. For water, it is still arranged properly with orientational order, but for silica, the second shell is randomly smeared around with little orientational order.

 

“In water, the locally ordered structures are precursors to ice; that is, tetrahedral crystals of H2O,” co-author Rui Shi explains. “The orientational ordering, or rotational , in a explains why water freezes so easily. In supercooled silica, however, the lack of orientational ordering prevents crystallization, resulting in easy glass formation. In other words, the is harder to break in silica’s liquid structure, and with less orientational order.”

 

The researchers explain this difference by comparing the bonding in the two substances. Water consists of individual H2O molecules, held together by strong covalent bonds but interacting via weaker hydrogen bonds. The stable molecular structure of water restricts the freedom of atoms, resulting in high orientational order in water. Silica, however, has no molecular form, and are resultantly bonded in a less directional way, leading to poor orientational order.

 

“We showed that the macroscopic differences between water and silica originate in the microscopic world of bonding,” corresponding author Hajime Tanaka says. “We hope to extend this principle to other substances, such as liquid carbon and silicon, that are structurally similar to and . The ultimate goal is to develop a general theory of how glass-formers differ from crystal-formers, which is something that has eluded scientists thus far.”

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Phys.org – latest science and technology news stories] February 14, 2018 at 06:30AM. Credit to Author and Phys.org – latest science and technology news stories | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Stronger Than Steel, Able to Stop a Speeding Bullet–It’s Super Wood!

Your daily selection of the latest science news!

According to Scientific American Content: Global


Some varieties of wood, such as oak and maple, are renowned for their strength. But scientists say a simple and inexpensive new process can transform any type of wood into a material stronger than steel, and even some high-tech titanium alloys. Besides taking a star turn in buildings and vehicles, the substance could even be used to make bullet-resistant armor plates.

 

Wood is abundant and relatively low-cost—it literally grows on trees. And although it has been used for millennia to build everything from furniture to homes and larger structures, untreated wood is rarely as strong as metals used in construction. Researchers have long tried to enhance its strength, especially by compressing and “densifying” it, says Liangbing Hu, a materials scientist at the University of Maryland, College Park. But densified wood tends to weaken and spring back toward its original size and shape, especially in humid conditions.

 

Now, Hu and his colleagues say they have come up with a better way to densify wood, which they report in the February 7 Nature. Their simple, two-step process starts with boiling wood in a solution of sodium hydroxide (NaOH) and sodium sulfite (Na2SO3), a chemical treatment similar to the first step in creating the wood pulp used to make paper. This partially removes lignin and hemicellulose (natural polymers that help stiffen a plant’s cell walls)—but it largely leaves the wood’s cellulose (another natural polymer) intact, Hu says.

 

The second step is almost as simple as the first: Compressing the treated wood until its cell walls collapse, then maintaining that compression as it is gently heated. The pressure and heat encourage the formation of chemical bonds between large numbers of hydrogen atoms and neighboring atoms in adjacent nanofibers of cellulose, greatly strengthening the material.

 

The results are impressive. The team’s compressed wood is three times as dense as the untreated substance, Hu says, adding that its resistance to being ripped apart is increased more than 10-fold. It also can become about 50 times more resistant to compression and almost 20 times as stiff. The densified wood is also substantially harder, more scratch-resistant and more impact-resistant. It can be molded into almost any shape. Perhaps most importantly, the densified wood is also moisture-resistant: In lab tests, compressed samples exposed to extreme humidity for more than five days swelled less than 10 percent—and in subsequent tests, Hu says, a simple coat of paint eliminated that swelling entirely.

 

A five-layer, plywoodlike sandwich of densified wood stopped simulated bullets fired into the material—a result Hu and his colleagues suggest could lead to low-cost armor. The material does not protect quite as well as a Kevlar sheet of the same thickness—but it only costs about 5 percent as much, he notes.

 

The team’s results “appear to open the door to a new class of lightweight materials,” says Ping Liu, a materials chemist at the University of California, San Diego, unaffiliated with the Nature study. Vehicle manufacturers have often tried to save weight by switching from regular steel to high-strength steel, aluminum alloys or carbon-fiber composites—but those materials are costly, and consumers “rarely make that money back in fuel savings,” Liu says. And densified wood has another leg up on carbon-fiber composites: It does not require expensive adhesives that also can make components difficult, if not impossible, to recycle.

 

Densified wood provides new design possibilities and uses for which natural wood is too weak, says Peter Fratzl, a materials scientist at the Max Planck Institute of Colloids and Interfaces in Germany who did not take part in the study. “Instead of creating a design for the material at hand, researchers can create a material to suit the design they want,” he says, alluding to a familiar process among aerospace engineers who have a long history of developing ever-stronger alloys to meet their needs.

 

One possible obstacle to the widespread use of densified wood will be engineers’ ability to scale up and accelerate the process, Liu notes. Hu and his team spent several hours making each coffee-table book–size slab of densified wood used for testing. But there are no practical reasons the process could not be sped up or used to make larger components, Hu contends.

 

Although Hu and his team have sought to enhance wood’s strength, other researchers have pursued more unusual goals—such as making it transparent. One team, led by materials scientist Lars Berglund at the KTH Royal Institute of Technology in Stockholm, has come up with a way to make windowpanes of wood. The first step in that process (as in Hu’s) is to remove lignin, a substance that not only stiffens wood but also creates its brownish color. The researchers infuse the lignin-free wood with a polymer called methyl methacrylate (MMA), a material better known by trade names such as Plexiglas and Lucite.

 

Because MMA’s index of refraction (a measure of how much it bends light) matches that of the lignin-free wood, rays of light pass right through the MMA-infused composite instead of getting bounced around inside empty cells. This renders the material remarkably clear. Berglund and his team described their feat two years ago in Biomacromolecules.

 

Research like Hu’s and Berglund’s can only add to the wild prospects for the future of materials science. Someday soon it might be possible to live in a home made almost completely from one of Earth’s most abundant and versatile building materials—from  floors to rafters, walls to windows. In the garage there may be a car whose chassis and bumpers could be composed of densified wood rather than steel and plastic—knock on wood.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Scientific American Content: Global] February 7, 2018 at 01:01PM. Credit to Author and Scientific American Content: Global | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

First flashes of light observed from individual graphene nanoribbons

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories

graphene nanoribbons
A graphene nanoribbon is partially suspended by a microscope tip, resulting in bright light emission. Credit: Chong et al. ©2017 American Chemical Society

For the first time, researchers have experimentally observed light emission from individual graphene nanoribbons. They demonstrated that 7-atom-wide nanoribbons emit light at a high intensity that is comparable to bright light-emitting devices made from carbon nanotubes, and that the color can be tuned by adjusting the voltage. The findings may one day lead to the development of bright graphene-based light sources.

The researchers, led by Deborah Prezzi at the CNR-Nanoscience Institute in Modena, Italy, and Guillaume Schull at the University of Strasbourg in France, have published a paper on their observations of the first electroluminescence from individual nanoribbons in a recent issue of Nano Letters.

 

“Generally, molecular-scale devices are interesting fundamental systems, but are rather unstable and produce limited amount of signal,” Schull told Phys.org. “In our article, we prove that individual graphene nanoribbons may be used as intense, stable and controllable sources. These are decisive steps towards real-world optoelectronic applications with nanoscale organic systems.”

 

Although graphene’s excellent electronic properties have been investigated extensively, much less is known about its optical properties. One of the drawbacks of using graphene as a light-emitting is that graphene sheets do not have an optical band gap. However, recent studies have shown that, when cut into thin ribbons just a few atoms wide, graphene obtains a sizable optical band gap, opening up the possibility of .

 

Experimentally, there have been only a few demonstrations of light emission from graphene nanoribbons, and these have been limited to ensembles of nanoribbons and revealed only weak light emission. So the results of the new study, which show a much brighter light emitted by individual graphene nanoribbons compared to ensembles, hint at the exciting untapped potential of graphene’s optical properties.

 

As the researchers explain in the new study, they used a novel configuration method in which an individual graphene nanoribbon bridges two metallic electrodes, for the first time forming an electronic circuit. Using a microscope tip, the researchers partially lifted the nanoribbon so that it lay partly on the substrate and partly suspended. This configuration reduces the coupling between the nanoribbon and the electrodes that would otherwise quench the light emission.

 

Tests showed that the individual graphene nanoribbons exhibit an intense optical emission of up to 10 million photons per second, which is 100 times more intense than the emission measured for previous single-molecular optoelectronic devices, and comparable to that measured for bright light-emitting devices made of carbon nanotubes.

 

In addition, the researchers found that the energy shift of the main peak changes as a function of the voltage, which provides a way to tune the color of the light. These observations also offer insight into the underlying mechanisms of the light from individual graphene nanoribbons, which the researchers plan to further investigate in the future.

 

“We likely will explore the influence of the width of the graphene nanoribbons on the color of the emitted light, as the width is expected to control the size of the gap,” Schull said. “The impact of defects should also be explored. Eventually, one should propose methods to integrate our graphene nanoribbons devices in larger circuitry.”


Explore further:
Chemists synthesize narrow ribbons of graphene using only light and heat

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Phys.org – latest science and technology news stories] January 10, 2018 at 09:33AM. Credit to Author and Phys.org – latest science and technology news stories | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Taking ibuprofen for long periods found to alter human testicular physiology

Your daily selection of the latest science news!

According to Medical Xpress

https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/hires/2017/ibuprofen.jpg
Credit: CC0 Public Domain

A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published in Proceedings of the National Academy of Sciences, the group describes their study, which involved giving the drug to volunteers and monitoring their hormones and sperm production.

To learn more about the possible impacts of the popular anti-inflammation Ibuprofen on when taken for long periods of time, the researchers asked 31 men between the ages of 18 and 35 to take 600 milligrams (three tablets) a day of the drug for six weeks. Other volunteers were given a placebo. Over the course of the study, the volunteers were tested to see what impact the drug had on their bodies.

The researchers report that just two weeks into the study, they found that all of the volunteers had an increase in luteinizing hormones, which the male body uses to regulate the production of testosterone. The increase indicated that the drug was causing problems in certain cells in the testicles, preventing them from producing testosterone, which is, of course, needed to produce sperm cells. They further report that the change caused the to respond by producing more of another hormone, which forced the body to produce more testosterone. The net result was that overall testosterone levels remained constant, but the body was overstressing to compensate for the detrimental impact of the Ibuprofen—a state called compensated hypogonadism.

The researchers note that while compensated hypogonadism can cause a temporary reduction in the production of , reducing fertility, it is generally not cause for alarm. What is more of a concern, they note, is using the drug for longer periods of time. It has not been proven yet, but the researchers suspect such use, as is seen with some professional athletes or others with chronic pain issues, might lead to a condition called overt primary hypogonadism, in which the symptoms become worse—sufferers report a reduction in libido, muscle mass and changes in mood. Additional studies are required, they note, to find out if this is, indeed, the case.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Medical Xpress] January 9, 2018 at 08:59AM. Credit to Author and Medical Xpress | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

General anesthetics do more than put you to sleep

Your daily selection of the latest science news!

According to Medical Xpress

General anesthetics do more than put you to sleep
A representation of thousands of tracked syntaxin1A molecules in a neuron exposed to propofol. Credit: Associate Professor Bruno van Swinderen

A new understanding of the complex ways in which general anaesthetics act on the brain could eventually lead to improved drugs for surgery. It remains unclear how general anaesthesia works, even though it is one of the most common medical procedures worldwide.

University of Queensland researcher, Associate Professor Bruno van Swinderen, said his team had overturned previous understanding of what do to the , finding the drugs did much more than induce sleep.

 

“We looked at the effects of propofol – one of the most common general anaesthetic drugs used during surgery – on synaptic release,” the UQ Queensland Brain Institute scientist said.

 

Synaptic release is the mechanism by which neurons – or nerve cells – communicate with each other.

 

“We know from previous research that general anaesthetics including propofol act on sleep systems in the brain, much like a sleeping pill,” Associate Professor van Swinderen said.

 

“But our study found that propofol also disrupts presynaptic mechanisms, probably affecting communication between neurons across the entire brain in a systematic way that differs from just being asleep. In this way it is very different than a sleeping pill.”

 

PhD student Adekunle Bademosi said the discovery shed new light on how general anaesthetics worked on the brain.

 

“We found that propofol restricts the movement of a key protein (syntaxin1A) required at the synapses of all neurons. This restriction leads to decreased communication between neurons in the brain,” he said.

 

Associate Professor van Swinderen said the finding contributed to understanding how general anaesthetics worked, and could explain why people experienced grogginess and disorientation after coming out of surgery.

 

“We think that widespread disruption to synaptic connectivity – the brain’s communication pathways – is what makes surgery possible, although effective anaesthetics such as do put you to sleep first,” he said.

 

“The discovery has implications for people whose brain connectivity is vulnerable, for example in children whose brains are still developing or for people with Alzheimer’s or Parkinson’s disease.

 

“It has never been understood why general anaesthesia is sometimes problematic for the very young and the old. This newly discovered may be a reason.”

 

Associate Professor van Swinderen said more research was needed to determine if general anaesthetics had any lasting effects in these vulnerable groups of people.

 

“Studying these effects in model systems such as rats and flies allows us to address these questions by manipulating the likely mechanisms involved, which we can’t do in humans.”

 

The research involved Professor Frederic Meunier’s laboratory at QBI, where super-resolution microscopy techniques enabled the researchers to understand how the worked on single cells. Dr Victor Anggono, whose laboratory at QBI focusses on synaptic mechanisms, was a partner in the study.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Medical Xpress] January 9, 2018 at 12:03PM. Credit to Author and Medical Xpress | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

See-through metals

Your daily selection of the latest science news!

According to ESA Top News

Microscopic metal

Astronauts on the International Space Station have begun running an experiment that could shine new light on how metal alloys are formed.

How humanity has mastered metallurgy is synonymous with progress, with historians labelling periods such as the Bronze Age and the Iron Age.

Most metals used today are mixtures – alloys – of different metals, combining properties to make lighter and stronger materials.

Like baking a cake, the result depends on more than just adding the right ingredients: casting is influenced by furnace temperatures and the cooling process. Some metals are even cast in hypergravity centrifuges in the quest for the perfect alloy.

Alloys are everywhere now, from the smartphone in your pocket to aircraft. Making lighter, resistant, self-healing or even supple alloys obviously benefits industry and consumers alike.

Solving the problem of transparency

It is no wonder that we would love to peer into the inner workings of metal casting to see what is happening with our own eyes. Ideally, we should observe the process without gravity adding its extra layer of complexity. The problem, of course, is that metals are not transparent.


 

Transparent alloy furnace

ESA is running X-ray experiments on suborbital rockets but these are limited to 13 minutes of weightlessness at a time and X-rays do not reveal all.

Instead, researchers looked at a stand-in for metals and found organic materials, carefully chosen to be transparent while solidifying like a metal.

A first batch of mixtures arrived at the Space Station on 18 December: succinonitrile, D-camphor and neopentyl glycol were delivered by a Dragon spacecraft inside a glass-wall cartridge together with a miniature toaster. This Bridgman furnace is similar to a conveyor-belt oven found in factories or fast-food restaurants. The cartridges pass through the heating element at an agonisingly slow pace: they take upwards of two days to travel 1 mm, but the experiment will run on its own for several weeks.

Melting plastic

An astronaut set up the Transparent Alloy furnace inside ESA’s self-contained glovebox for safety and inserted the first cartridge.


 

Monitoring progress

A hard disk is recording the microscopic view from two video cameras, while operators at the Spanish control centre in Madrid can highlight different features using an array of coloured lights.

These experiments into fundamental phenomena are allowing scientists to understand and then control processes. Who knows what amazing metals might be created? The next metal age might just be something we can’t imagine right now.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [ESA Top News] January 9, 2018 at 11:17AM. Credit to Author and ESA Top News | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Save a snowflake for decades

Your daily selection of the latest science news!

According to Popular Science


Ever wanted to catch a snowflake and keep it forever? You can. The image above is a photograph of a snowflake that fell in January 1979, but it isn’t an old photo. It is a recent shot of a snowflake that’s been sitting in chemist Tryggvi Emilsson’s desk for decades, locked in a drop of that miracle of modern chemistry we call superglue.

The “super” in the thin, runny adhesive, which was invented during World War II, is the small molecules in it called cyanoacrylate monomers that penetrate and interlock with the microscopic forms of anything they touch. The glue hardens when the monomers link together, or polymerize, head-to-tail into long chains called polymers. This process is triggered by any minute trace of water or water vapor and progresses very quickly, which is why superglue hardens more rapidly on moist things, such as your fingers, than on the thing you’re trying to glue.

The tendencies of superglue to seep into the tiniest nooks and crannies, harden on contact with water, and solidify rapidly make it perfect for taking an impression of something very small, made of water, and ephemeral, a fact that struck Emilsson during the winter of ’79.

He’d been fascinated by Wilson A. Bentley’s famous 1931 book Snow Crystals, which contains 2,453 snowflake photographs taken over 47 freezing Vermont winters. Bentley had to work quickly to get each shot before the radiant heat from his body melted the flake. Despite being from Iceland (or perhaps because of it), Emilsson wasn’t about to endure long bouts of biting cold, so he came up with the superglue method described below, which lets you capture snowflakes outside and examine them later in the comfort of your living room. In front of a crackling fire, if you like.

Bentley could save just photographs, not the real snowflakes he longed as a child to take home to show his mother. One can only imagine what a collection he would have built if he’d had a few hundred tubes of superglue. Perhaps we’ll see when a modern-day Bentley comes along. Who knows, maybe it’s you.

Project stats

  • Cost: $10
  • Time: 10 minutes
  • Difficulty: Easy

Tools and materials

  • Microscope slides and coverslips
  • Tweezers (optional)
  • Superglue
  • Cold, snowy day

Instructions

  1. Set microscope slides, coverslips, and superglue outside when it’s 20°F or colder to chill them. Catch flakes on the slides or pick them up with cold tweezers.
  2. Place a drop of superglue on the snowflake. Note: Gel glue doesn’t work. Find a brand that’s thin and runny.
  3. Drop a coverslip over the glue. Don’t press down hard or the flake could tear or melt from the heat of your finger.
  4. Leave the slide in a freezer for one or two weeks and don’t touch it with warm hands. The glue must completely harden before the snowflake warms up.

This article was originally published in the March 2006 issue of Popular Science, under the title “Save a Snowflake for Decades.”

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Popular Science] December 27, 2017 at 01:11PM. Credit to Author and Popular Science | ESIST.T>G>S Recommended Articles Of The Day

 

 

 

Addicted to Your Phone? It Could Throw Off Your Brain Chemistry

Your daily selection of the latest science news!

According to Live Science

2

 

It’s hard to escape screens; there is a roughly 100 percent chance you are looking at one right now. And though the long-term effects of screen time are still being studied, the effects of excessive internet and smartphone use are well-documented. “Pathological” internet use has been linked to depression in teens, and it may even shrink gray matter.Now, a small new study suggests that for teens, being hooked on the internet and smartphones may harm brain chemistry, as well.

The research was presented yesterday (Nov. 30) at the Radiological Society of North America’s annual meeting in Chicago.The paper, which was presented by lead study author Dr. Hyung Suk Seo, a professor of neuroradiology at Korea University in Seoul, South Korea, found an imbalance of chemicals in the brain of “internet-addicted” teenagers. This imbalance was similar to that seen in people experiencing anxiety and depression. [9 Odd Ways Your Tech Devices May Injure You]

But there’s also good news: The imbalance is reversible in several weeks using a type of psychotherapy called cognitive behavioral therapy.

In the study, researchers examined the brains of 19 internet- and smartphone-addicted teenagers and 19 nonaddicted teenagers using magnetic resonance spectroscopy, a form of MRI that can reveal changes in the chemical composition of the brain. (Internet and smartphone addiction were measured using standardized questionnaires.)

Compared with the control group, the teens with internet and smartphone addiction showed a clear overabundance of a neurotransmitter called gamma-aminobutyric acid (GABA) in one region of the limbic system, the brain’s emotional control center. GABA is an inhibitory neurotransmitter, meaning that it blocks nerve cells from firing.

GABA is found in everyone’s brain, but too much of this neurotransmitter in the wrong areas can have stultifying effects.”When the normal function of the limbic system is disturbed, patients can develop anxiety, depression or addiction,” said Dr. Max Wintermark, a professor of radiology and the chief of neuroradiology at Stanford University. Wintermark was not involved with the new research but said that he was intrigued by it because of the increasing prevalence of phones and web devices in society.

“There have been multiple studies published [that link] addiction to alcohol and other substances with chemical imbalances in different regions of the brain, but this is the first study I’ve read about internet addiction” that shows such a link, Wintermark told Live Science.

For most people, checking email first thing in the morning or spending an hour scrolling though Instagram after work does not signify an internet addiction.

Rather, internet addiction, as defined by the American Psychiatric Association, is an excessive use of the internet that leads to impairment of everyday life, sleep and relationships. Studies from around the world have found that the rates of internet addiction in young people range from less than 1 percent to 18 percent.

The teens who participated in Seo’s study all took standardized tests used to diagnose internet and smartphone addiction. The participants whose scores indicated an addiction  tended to saythat their internet and smartphone use interfered with their daily routines, social lives, sleep and productivity. These teenagers also had significantly higher scores in depression, anxiety, insomnia and impulsivity than the control group (the participants whose scores did not indicate internet addiction).

Due to the small sample size used in the study, Wintermark stressed that it’s too early to say that the chemical imbalances observed in the teens’ brains are linked to clinical problems such as anxiety and depression. Further testing on a larger group of people is needed, he said.

Wintermark noted that 12 teens in the study with addiction went on to participate in cognitive behavioral therapy, and after nine weeks, they all showed decreased or normalized levels of GABA in their brains. According to the researchers, those teens completed a modified form of therapy that’s used to treat video game addiction, involving weekly 75-minute sessions of mindfulness exercises. These include recognizing internet impulses, finding alternative activities and expressing emotions.

“With appropriate intervention, the teens were able to basically correct those chemical changes” in their brains, Wintermark said. “That’s the part of the study I find most interesting. It shows there’s hope.”

The study has not yet been published in a peer-reviewed journal.

Read more…

  • Got any news, tips or want to contact us directly? Email esistme@gmail.com

__

This article and images were originally posted on [Live Science] December 1, 2017 at 12:00PM. Credit to Author and Live Science | ESIST.T>G>S Recommended Articles Of The Day

Engineers 3-D print high-strength aluminum, solve ages-old welding problem using nanoparticles

The nanoparticle-functionalized powder is fed into a 3-D printer, which layers the powder and laser-fuses each layer to construct a three-dimensional object. Credit: B. Ferguson – HRL Laboratories

Your daily selection of the latest science news!

According to Phys.org – latest science and technology news stories

1.jpg

With this exciting new technique, HRL stands at the forefront of a new chapter in additive manufacturing of metals for research, industry, and defense. Credit: M. Durant HRL Laboratories

HRL Laboratories has made a breakthrough in metallurgy with the announcement that researchers at the famous facility have developed a technique for successfully 3D printing high-strength aluminum alloys—including types Al7075 and Al6061—that opens the door to additive manufacturing of engineering-relevant alloys.

These alloys are very desirable for aircraft and automobile parts and have been among thousands that were not amenable to additive manufacturing—3D printing—a difficulty that has been solved by the HRL researchers. An added benefit is that their method can be applied to additional alloy families such as high-strength steels and nickel-based superalloys difficult to process currently in additive manufacturing.

 

“We’re using a 70-year-old nucleation theory to solve a 100-year-old problem with a 21st century machine,” said Hunter Martin, who co-led the team with Brennan Yahata. Both are engineers in the HRL’s Sensors and Materials Laboratory and PhD students at University of California, Santa Barbara studying with Professor Tresa Pollock, a co-author on the study. Their paper 3D printing of high-strength aluminum was published in the September 21, 2017 issue of Nature.

Additive manufacturing of metals typically begins with alloy powders that are applied in thin layers and heated with a laser or other direct heat source to melt and solidify the layers. Normally, if high-strength unweldable aluminum alloys such as Al7075 or AL6061 are used, the resulting parts suffer severe hot cracking—a condition that renders a metal part able to be pulled apart like a flaky biscuit.

HRL’s nanoparticle functionalization technique solves this problem by decorating high-strength unweldable alloy powders with specially selected . The nanoparticle-functionalized powder is fed into a 3D printer, which layers the powder and laser-fuses each layer to construct a three-dimensional object. During melting and solidification, the nanoparticles act as nucleation sites for the desired alloy microstructure, preventing hot cracking and allowing for retention of full alloy strength in the manufactured part.

Read more…

__

This article and images were originally posted on [Phys.org – latest science and technology news stories] September 20, 2017 at 01:09PM

Credit to Author and Phys.org

 

 

 

Keep on marching for science education

Your daily selection of the latest science news!

According to Nature – Issue – nature.com science feeds

The new school year is beginning in the United States, and science education in Florida is at risk from laws that passed earlier this summer. It leaves me wondering: where have those who joined April’s March for Science gone?

That global action was probably the most popular science-advocacy event of this generation. I took part in Titusville, Florida, and was impressed with the attendance, enthusiasm and creative slogans. In the speeches that followed, I warned against pending legislation that would allow any citizen to demand a hearing to challenge instructional materials. Both critics and advocates see this as a way to stifle teaching about evolution and climate change. We had the summer to make our case.

The science-advocacy group Florida Citizens for Science — for which I volunteer as a board member and communications officer — led the battle to kill, or least modify, those bills. We lost on all fronts. The bills are now law.

Where were those marchers when we needed them? I know several science cheerleaders who took some concrete steps to forestall the legislation (by phoning elected representatives, for example), but I can count on one hand the number of working scientists who offered their expertise to our group. And I didn’t hear of any who approached lawmakers on their own.

Having the scientific community more actively involved might have had an impact. The final vote in the state senate was tight. Advocates of the law were widely quoted as claiming that evolution is just a theory and that anthropogenic global warming is in doubt. It would have been invaluable if scientists at local universities had issued simple statements: yes, evolution is a fact; the word ‘theory’ is used differently in science from how it’s used in casual conversation; and the basics of human-caused global warming need to be taught. Perhaps authoritative voices from the state’s universities would have swayed a senator or two.

Since the laws were passed, dozens of articles about them have been published statewide and even nationally. Social media has been buzzing. But the scientific community is still woefully quiet.

Hey, scientists, beleaguered high-school science teachers could use your support.

Other US states have endured attacks on science education. Legislatures in Alabama and Indiana passed non-binding resolutions that encourage ‘academic freedom’ for science teachers who cover topics — including biological evolution and the chemical origins of life — that the lawmakers deem controversial.

In Iowa, state lawmakers proposed a law requiring teachers to balance instruction on evolution and global warming with opposing views. That effort dwindled without concrete action, but not because of pressure from the scientific community.

“Hey, scientists, beleaguered high-school science teachers could use your support.”

We have had some help in our efforts: Jiri Hulcr and Andrea Lucky, scientists at the University of Florida in Gainesville, spoke out with me against these bad educational bills in a newspaper opinion piece. We argued that the choice was stark: training students for careers in the twenty-first century, or plunging them into the Middle Ages.

And Paul D. Cottle at Florida State University in Tallahassee is unrelenting in pursuing his goal of preparing elementary and high-school students for their adult lives. He’s an integral part of Future Physicists of Florida, a middle-school outreach programme that identifies students with mathematical ability and guides them into courses that will prepare them for university studies in science and engineering. More generally, he makes sure that students, parents and school administrators hear the message that the path to high-paying, satisfying careers using skills acquired in mathematics and science starts long before university, and depends on accurate instruction.

Plenty of issues need attention. The pool of qualified science and maths teachers is shrinking. Florida students’ performance in state-mandated science exams has been poor and stagnant for nearly a decade. This year, the state’s education department will begin to review and select science textbooks that will be used in classrooms across the state for at least the next five years.

We need scientists who are willing to take the time and effort to push back against the textbook challenges that these new laws will encourage. We need expert advisers eager to review and recommend quality science textbooks for our schools. We need bold scientists ready to state unapologetically that evolution, global warming — and, yes, even a round Earth — are facts of life.

You’re busy. I know. And some of you are uncomfortable in the spotlight. But doing something, even on a small scale, is better than doing nothing. Sign up for action alerts from the National Center for Science Education and your state’s science-advocacy group, if you have one. Be a voice within any organizations you belong to, urging them to make statements supporting science education as issues arise. Introduce yourself to teachers at local elementary and high schools.

Even if all you have to offer are ideas and emotional support, we’ll take them. Politicians, school administrators, business leaders, parents and even children need to know that you support high-quality science education.

The March for Science was a beneficial, feel-good event. It’s over. But we need you to keep on marching!

Read more…

__

This article and images were originally posted on [Nature – Issue – nature.com science feeds] August 30, 2017 at 01:07PM

Credit to Author and Nature

 

 

 

Confirmed: Electrons Flowing Like Liquid in Graphene Are Insanely Superconductive

Your daily selection of the latest science news!

According to ScienceAlert

Electrons have been caught flowing through graphene like a liquid, reaching limits physicists thought were fundamentally impossible.

This type of conductance is known as ‘superballistic’ flow, and this new experiment suggests it could revolutionise the way we conduct electricity.

If that’s not crazy enough, the super-fast flows actually occur as a result of electrons bouncing off each other, something that high school physics tells us should slow conductivity down.

So what’s going on here? For decades, scientists had speculated that, under some circumstances, electrons might stop behaving as individuals and collide so often that they actually begin to flow like a viscous fluid with all kinds of unique properties.

But it was only last year that researchers confirmed the phenomenon, showing for the first time that, even at room temperature, electrons within graphene could act as a fluid 100 times more viscous than honey – something the researchers referred to as “quantum weirdness arising from [electrons’] collective motion“.

Now the same team, led by Sir Andre Geim – the University of Manchester physicist who won the 2010 Nobel Prize for his work characterising graphene – has shown that this liquid electron phenomenon is even crazier than we thought.

Read more…

__

This article and images were originally posted on [ScienceAlert] August 23, 2017 at 12:14AM

Credit to Author and ScienceAlert

 

 

 

Breakthrough ink discovery could transform the production of new laser and optoelectronic devices

The research titled Black phosphorus ink formulation for inkjet printing of optoelectronics and photonics has been published today in Nature Communications and was funded by the Royal Academy of Engineering and the Engineering and Physical Sciences Research Council (EPSRC).

Your daily selection of the latest science news!

According to Phys.org 

1.jpg

Black phosphorus (BP) crystal before it is converted into functional ink. Credit: smart-elements.com

A breakthrough ‘recipe’ for inkjet printing, which could enable high-volume manufacturing of next-generation laser and optoelectronic technologies, has been uncovered by Cambridge researchers.

The research, led by Dr Tawfique Hasan, of the Cambridge Graphene Centre, University of Cambridge, found that Black phosphorous (BP) ink – a unique two-dimensional material similar to graphene – is compatible with conventional inkjet techniques, making possible – for the first time – the scalable mass manufacture of BP-based laser and .

An interdisciplinary team of scientists from Cambridge as well as Imperial College London, Aalto University, Beihang University, and Zhejiang University, carefully optimised the chemical composition of BP to achieve a stable ink through the balance of complex and competing fluidic effects. This enabled the production of new functional laser and optoelectronic devices using high-speed printing.

Read more…

__

This article and images were originally posted on [Phys.org – latest science and technology news stories] August 17, 2017 at 08:33AM

Credit to Author and Phys.org

 

 

 

What Is Science?

Science is a systematic and logical approach to discovering how things in the universe work. It is also the body of knowledge accumulated through the discoveries about all the things in the universe. 

Your daily selection of the latest science news!

Source: Live Science 

Science is a systematic and logical approach to discovering how things in the universe work. It is also the body of knowledge accumulated through the discoveries about all the things in the universe.

The word “science” is derived from the Latin word scientia, which is knowledge based on demonstrable and reproducible data, according to the Merriam-Webster Dictionary. True to this definition, science aims for measurable results through testing and analysis. Science is based on fact, not opinion or preferences. The process of science is designed to challenge ideas through research. One important aspect of the scientific process is that it is focuses only on the natural world, according to the University of California. Anything that is considered supernatural does not fit into the definition of science.

Read more…

__

This article and images were originally posted on [Live Science] August 7, 2017 at 11:08AM

Credit to Author and Live Science

Early Clinical Trial Shows ‘Cancer Vaccines’ Can Protect Humans From Tumours

New hope.

Cancer comes in many different forms, and it is not unusual for diagnosed patients to endure multiple kinds of treatments before one that is effective against their particular form of cancer is found.

If it takes too long for doctors to find the right treatment, the consequences can be fatal.

The severity of cancer has fuelled physicians and scientists from all walks of life to explore any possible solution, including those that seem natural to those that may at times seem unconventional.

Well, researchers are now taking vaccines, which typically target viruses and bacteria, and reworking them to zero in on the patient’s specific cancer cells.

Physicians and scientists led by Catherine Wu at the Dana-Farber Cancer Institute in Boston just presented their results of their new cancer therapy to the American Association for Cancer Research (AACR) in Washington, DC.

Their personalised vaccines have prevented early relapse in 12 patients with skin cancer, while also boosting patient immunity when combined with a cancer drug.

While earlier cancer vaccines targeted a singular cancer protein found ubiquitously among patients, these personalised vaccines contain neoantigens, which are mutated proteins specific to an individual patient’s tumour.

These neoantigens are identified once a patient’s tumour is genomically sequenced, providing physicians with the information they need to pinpoint unique mutations.

Once a patient’s immune system is provided a dose of the tumour neoantigens, it can activate the patient’s T cells to attack cancer cells.

Unlike previous attempts towards cancer vaccines, which did not produce conclusive evidence in halting cancer growth, Wu’s team made their personal vaccine much more specific to each patient’s cancer, targeting about 20 neoantigens per patient.

The vaccines were injected under the patients’ skin for a period of five months and indicated no side effects and a strong T cell response.

All of Wu’s patients who were administered the personal vaccine are still cancer-free more than 2.5 years after the trial.

However, some patients with an advanced forms of cancer also needed an some extra punching power to fend off their diseases.

Two of Wu’s patients who did relapse were administered an immunotherapy drug, PD-1 checkpoint inhibitor, in addition to the personalised vaccine.

Working in conjunction with the enhanced T cell response from the vaccine, the drug makes it difficult for the tumour to evade the immune cells. The fusion of the two therapies eliminated the new tumours from both patients.

But we can’t get too excited yet. While these results are promising, the therapies are relatively new and require much more clinical testing.

Many physicians around the world are working together to test the potency of neoantigens in order to verify if the vaccine works better than current immunotherapy drugs over a sustainable period of time.

Personalised vaccines are costly and take months to create, a limiting factor in providing care to patients with progressing cancers.

Still, this study is an encouraging sign for many oncologists who are interested in using the immune system to fight cancer.

More than a million new patients are diagnosed with cancer each year in the U.S. alone, and even in situations where the cancer is treatable, the available chemotherapy agents themselves can be very toxic.

If proven safe and effective, this personalised cancer vaccine could give patients around the world hope for powerful treatment with fewer side effects.

__

Join our fans by liking us on Facebook, or follow us on Twitter, Google+, feedly, flipboardand Instagram.

This article and images was originally posted on ScienceAlert | Futurism

By NEIL C. BHAVSAR & CHRISTIANNA REEDY, FUTURISM

 

 

 

Neil deGrasse Tyson Warns Science Denial Could ‘Dismantle’ Democracy

Neil deGrasse Tyson says that when people who deny science rise to power that is a recipe for a complete dismantling of our democracy.

Credit: Redglass Pictures/YouTube

Renowned astrophysicist Neil deGrasse Tyson urges Americans to become more scientifically literate in a short video he posted yesterday (April 19) on his Facebook page.

 
In the video he titled “Science in America,” Tyson comments on 21st-century attitudes toward science, explaining the importance of the scientific method and making the case that science denial could erode democracy.

 
“Dear Facebook Universe,” he wrote. “I offer this four-minute video on ‘Science in America’ containing what may be the most important words I have ever spoken. As always, but especially these days, keep looking up.” [2017 March for Science: What You Need to Know]

 

 

 
Tyson, who is the director of the Hayden Planetarium in New York City, the author of several books and a star of TV and radio, has been speaking for years against the troubling decline of basic science knowledge in America.

 
The video begins with a reminder that the United States rose up from a “backwoods country,” as Tysoncalls it, to “one of the greatest nations the world has ever known,” thanks to science. It was the United States that put humans on the moon and whose big thinkers created the personal computer and the internet.

 
“We pioneered industries,” Tysonsaid. “Science is a fundamental part of the country that we are.”

 
But in the 21st century, a disturbing trend took hold: “People have lost the ability to judge what is true and what is not,” he said.

 
In a voice full of passion, Tyson said, “This is science,” as images flash across the screen showing the world’s great scientists from Albert Einstein to Jane Goodall, and scientific accomplishments, from ultrasound images of a fetus and robotic surgery to animations of solar flares and pictures of a swirling hurricane.

 
“It’s not something to say ‘I choose not to believe E = mc^2,’ you don’t have that option.”

 
Tyson points to scientific issues that have become highly controversial: vaccinations, human-caused climate change, genetically modified foods, even evolution. One clip shows Vice President Mike Pence, then a congressman, saying, “Let us demand that educators around America teach evolution not as fact, but as theory.” (Evolution is a scientific fact; so much so that the evidence supporting its occurrence is undeniable, according to the National Academy of Sciences.)

 
Tyson suggests that those who understand science the least are the people who are rising to power and denying it the loudest.

 
“That is a recipe for the complete dismantling of our informed democracy,” he said.

 
In about 30 seconds, Tyson explains how hypothesis and experimentation, fundamental ingredients of the scientific method, lead to emergent truths. “The scientific method does it better than anything else we have ever done as human beings,” he said.

 
Emergent scientific truths are true whether or not a person believes them, he said. “And the sooner you understand that, the faster we can get on with the political conversations about how to solve the problems that face us.”

 
Every minute a person is in denial only delays the political solution, he said. Tyson wants voters and citizens to learn what science is and how it works to make more informed decisions.

 
“It’s in our hands,” he said.

 
Original article on Live Science.

 

__

Join our fans by liking us on Facebook, or follow us on Twitter, Google+, feedly, flipboardand Instagram.

This article and images was originally posted on Live Science

By Tracy Staedter, Live Science Contributor

 

 

 

China is about to change the way it uses a last-resort antibiotic for the better—but it’s too late

This 2006 colorized scanning electron micrograph image made available by the Centers for Disease Control and Prevention shows the O157:H7 strain of the E. coli bacteria. On Wednesday, May 26, 2016, U.S. military officials reported the first U.S. human case of bacteria resistant to an antibiotic used as a last resort drug. The 49-year-old woman has recovered from an infection of E. coli resistant to colistin. But officials fear that if the resistance spreads to other bacteria, the country may soon see germs impervious to all antibiotics. (Janice Carr/CDC via AP)

China is about to make a major change to how it uses a last-resort antibiotic called colistin. As part of its efforts against antibiotic overuse, a global problem that has caused some bacteria to become resistant to drugs, China will entirely stop using the drug in animal feed from the end of this month (April 30). The change, announced late last year (link in Chinese), will also be accompanied by China switching to using the drug for human therapy, according to a paper in the Lancet published in January.

China’s doing the responsible thing, scientists say. And yet the shift could still be very bad for humans.

Colistin, which dates to the 1950s, is an antibiotic with serious side effects, particularly kidney damage, but doctors still turn to it when other options have failed, for example, for sepsis, or for lung and post-surgical infections.

China’s move will see more than 8,000 metric tons of colistin withdrawn from agricultural use. (Although China isn’t the only country to use antibiotics in animal feed, it is by far the largest user, followed by the US.) Antimicrobials are added to animal feed to prevent disease, and promote growth.

The worry is that when colistin is prescribed to humans in China, conditions will be ripe for the spread of colistin-resistant infections in people.

“The rest of the world has not used colistin as a growth promotor. Because of that, you have colistin resistance in the farming sector at a very high level,” says microbiology professor Timothy Walsh at the University of Cardiff, who participated in the Lancet study along with Professor Jianzhong Shen of China Agricultural University.

The drug’s decades-long widespread use in agriculture has helped bacteria in animals become resistant to it. Some bacteria have been found to have a colistin-resistant gene known as “mcr-1,” located on a small bit of DNA that can readily transfer from one bacteria to another.

The Lancet paper, funded by scientific institutions in China and the UK, looked at the prevalence of bacteria with the colistin-resistant gene in human infections in two hospitals in China, as well as risk factors for the presence of such bacteria. Research on the mcr-1 gene persuaded the Chinese government to impose the animal-feed ban, although colistin is still approved for treating sick animals, which Walsh also advocates stopping.

The mcr-1 gene was first detected in China in 2015; shortly after that, the gene was also found in bacteria in humans and food in countries like the US and Denmark.

China’s Food and Drug Administration referred Quartz to China’s Health and Family Planning Commission, the top lawmaking state agency for health. The commission hasn’t yet responded to a query about colistin use in humans. Liu Xiaolin, spokeswoman for China’s Antimicrobial Resistance Surveillance System, an organization founded in 2005 that answers to the health commission, said she did not have information about plans for the drug’s application.

While it’s unclear how China plans to instruct doctors to prescribe colistin, Walsh says it’s likely China will reserve it for the most difficult-to-treat cases, when tests show extensive resistance to other types of antibiotics, particularly the important class of antibiotics called carbapenems.

As other drugs increasingly fail to work, though, doctors in China may find that they have turned more frequently to colistin, like their counterparts in other parts of the world, as the development of new antibiotics has stagnated. “China has a growing problem in carbapenems resistance, so you are running out of options,” says Walsh.

This could also speed the impending arrival of another form of resistance scientists worry about—bacterial infections that don’t respond either to colistin or to carbapenems.

Biological sciences professor Michael Gillings of Australia’s Macquarie University, who was not involved in the Lancet study, says there are some steps that could help delay the appearance of new superbugs with resistance to both kinds of antibiotics.

The first thing, he says, is to use it judiciously: “Test people beforehand, to see if they have the mcr gene before [doctors] prescribe colistin,” says Gillings.

“The best possible thing is not to use colistin at all,” says Gilling, “But you know, I am not treating a dying patient.”

__

Join our fans by liking us on Facebook, or follow us on Twitter, Google+, feedly, flipboardand Instagram.

This article and images was originally posted on Quartz

by Echo Huang

 

 

 

Tyson: Trump’s anti-science budget will make America stupid again

President Donald Trump’s proposed budget eviscerates government funding for basic scientific research and development, taking a sledge hammer to education, health and environmental protection. In a series of Tweets posted on Sunday, astrophysicist and TV host Neil deGrasse Tyson indirectly took on Trump’s budget, writing that making America great won’t happen until we make America smart again by increasing government funding, not by ignoring the scientific consensus on man-made global warming and slashing financial support for important programs that improve the quality of life for American citizens and ensure a livable world.

 

 

Trump’s budget boosts Defense, Homeland Security and Veterans Affairs while proposing deep cuts to the Environmental Protection Agency (31.4%), Health and Human Services (16.2%), the State Department (28.7%), Commerce (15.7%), Transportation (12.7%), Labor (20.7%), Education (13.5%), Interior (11.7%), Agriculture (20.7%) and Housing and Urban Development (13.2%).

 

The budget would also eliminate or zero out programs including Advanced Research Projects Agency-Energy (ARPA-E), which funds clean energy research; Global Climate Change Initiative; Great Lakes Restoration Initiative; Chesapeake Bay funding; National Endowment for the Arts; National Endowment for the Humanities; NASA’s Office of Education; and TIGER transportation grants, a program included in the American Recovery and Reinvestment Act of 2009 that funds innovative transit projects.

Tyson isn’t the only scientist taking action against Trump’s war on science. The March for Science is scheduled for Earth Day, April 22nd in Washington, D.C. and cities across the country. The mission statement posted on the March for Science website calls for “robustly funded and publicly communicated science as a pillar of human freedom and prosperity. We unite as a diverse, nonpartisan group to call for science that upholds the common good and for political leaders and policy makers to enact evidence based policies in the public interest.”

__

join our fans by liking us on Facebook, or follow us on Twitter, Google+, feedly, flipboardand Instagram.

This article and images was originally posted on Huffington Post | inhabitat.com Image via Wikimedia

by

 

 

Scientists have found a way to rapidly thaw cryopreserved tissue without damage 

Researchers have developed a technique that allows them to rapidly thaw cryopreserved human and pig samples without damaging the tissue – a development that could help get rid of organ transplant waiting lists.

Cryopreservation is the ability to preserve tissues at liquid nitrogen temperatures for long periods of time and bring them back without damage, and it’s something scientists have been dreaming about achieving with large tissue samples and organs for decades.

Not only for the life-extending applications we’ve read about in sci-fi novels, but, more feasibly, because the technology could allow hospitals to safely store organs for long periods of time.

Right now, 22 people die in the US each day on average while waiting for an organ transplant. One of the biggest challenges isn’t organ shortages – it’s that organs can’t stay ‘on ice’ longer than a few hours without being irrevocably damaged.

That means even when there are enough organs being donated, there’s still the huge logistical problem in finding a matching recipient and getting the organs to them fast enough.

Already it’s estimated that more than 60 percent of the heart and lungs donated for transplantation each year are thrown out, because they can’t be kept on ice more than four hours, and can’t make it to a patient who needs them in that time.

“If only half of these discarded organs were transplanted, then it has been estimated that wait lists for these organs could be extinguished within two to three years,” the researchers, led by John Bischof from the University of Minnesota, write in Science Translational Medicine.

A better solution could be cryopreservation – keeping tissue stored at temperatures around -80 to -190 degrees Celsius (-112 to -310 degrees Fahrenheit).

One of the leading cryopreservation techniques is vitrification – which involves super-cooling biological samples to a glassy state at around -160 degrees Celsius (-256 degrees Fahrenheit). In fact, vitrification is already being used on human brains by cryonics companies such as Alcor.

Through vitrification, organs could be stored for years and potentially even longer, which would mean doctors could build up a bank of available organs and make it a lot easier for anyone who needs a heart or lung to find one straight away.

But while we’ve managed to get the cooling part down, the problem is that the thawing process can cause ice crystals to form and damage tissue, and potentially even crack it during the thawing process.

In the past, researchers have successfully shown that thawing can work in small tissue samples up to around 1 mL in volume. But as tissue gets larger, and approaches the size of entire human organs, the current leading technique of convection – slow warming over ice – doesn’t work.

That could be about to change, with the Minnesota team announcing the development of a new technique that’s allowed them to rapidly rewarm cryogenically treated human and pig samples without damaging delicate frozen tissues.

“This is the first time that anyone has been able to scale up to a larger biological system and demonstrate successful, fast, and uniform warming of hundreds of degrees Celsius per minute of preserved tissue without damaging the tissue,” said Bischof.

Instead of using convection, the team used nanoparticles to heat tissues at the same rate all at once, which means ice crystals can’t form, so they don’t get damaged.

manuchehrabadi1HRManuchehrabadi et al., Science Translational Medicine (2017)

To do this, the researchers mixed silica-coated iron oxide nanoparticles into a solution and generated uniform heat by applying an external magnetic field.

They then warmed up several human and pig tissue samples ranging between 1 and 50 mL, using either their new nanowarming technique and traditional slow warming over ice.

Each time, the tissues warmed up with nanoparticles displayed no signs of harm, unlike the control samples.

You can see the comparison below, with the nanowarming group on the left of the red line, and the control groups on the right:

manuchehrabadi2HRManuchehrabadi et al., Science Translational Medicine (2017)

Afterwards, they were able to successfully wash the nanoparticles away from the sample after thawing.

The team also tested out the heating in an 80 mL system – without tissue this time – and showed that it achieved the same critical warming rates as in the smaller sample sizes, suggesting that the technique is scalable.

“In short, nanowarming matches fast convective warming viability and biomechanical testing at 1 mL, is superior to convective warming at 50 mL, and is physically scalable to 80-mL systems,” the team writes.

“In the future, we believe that nanowarming can be applied to larger tissues and organs up to volumes of 1 litre and possibly beyond.”

You can see a video of tissue being thawed out in less than a minute below:

Video via ScienceAlert


The team admits that larger tissue – and even whole organs – will need to have the nanoparticles injected into them, rather than just sitting around them, to achieve the same uniform heating, but it’s something they want to try next.

It’s important to note that the team hasn’t successfully shown that their technique actually works on organs, which are made up of complex arrangements of multiple tissue types.

That’s something that will require a lot of optimisation and tweaking, so we’re a long way off being able to bring organs back from cryopreservation. But it’s the first time we’ve seen such large volumes of tissue successfully be thawed from a cryopreserved state, and that’s pretty exciting.

The research has been published in Science Translational Medicine.

Join our fans by liking us on Facebook, or follow us on Twitter, Google+, feedly, flipboardand Instagram.

This article and images was originally posted on ScienceAlert

by FIONA MACDONALD

 

 

 

Cell-infused gloves and bandages light up when in contact with certain chemicals

Cell-infused gloves and bandages light up when in contact with certain chemicals
Researchers have found that the hydrogel’s mostly watery environment helps keep nutrients and programmed bacteria alive and active. When the bacteria reacts to a certain chemical, the bacteria are programmed to light up, as seen on the left. Credit: Massachusetts Institute of Technology


Engineers and biologists at MIT have teamed up to design a new “living material”—a tough, stretchy, biocompatible sheet of hydrogel injected with live cells that are genetically programmed to light up in the presence of certain chemicals.

In a paper published this week in the Proceedings of the National Academy of Sciences, the researchers demonstrate the new material’s potential for sensing chemicals, both in the environment and in the human body.

The team fabricated various wearable sensors from the cell-infused hydrogel, including a rubber glove with fingertips that glow after touching a chemically contaminated surface, and bandages that light up when pressed against chemicals on a person’s skin.

Xuanhe Zhao, the Robert N. Noyce Career Development associate professor of mechanical engineering at MIT, says the group’s living material design may be adapted to sense other chemicals and contaminants, for uses ranging from crime scene investigation and forensic science, to pollution monitoring and medical diagnostics.

“With this design, people can put different types of bacteria in these devices to indicate toxins in the environment, or disease on the skin,” says Timothy Lu, associate professor of biological engineering and of electrical engineering and computer science. “We’re demonstrating the potential for living materials and devices.”

The paper’s co-authors are graduate students Xinyue Liu, Tzu-Chieh Tang, Eleonore Tham, Hyunwoo Yuk, and Shaoting Lin.

Infusing life in materials

Lu and his colleagues in MIT’s Synthetic Biology Group specialize in creating biological circuits, genetically reprogramming the biological parts in living cells such as E. coli to work together in sequence, much like logic steps in an electrical circuit. In this way, scientists can reengineer living cells to carry out specific functions, including the ability to sense and signal the presence of viruses and toxins.

However, many of these newly programmed cells have only been demonstrated in situ, within Petri dishes, where scientists can carefully control the nutrient levels necessary to keep the cells alive and active—an environment that has proven extremely difficult to replicate in synthetic materials.

“The challenge to making living materials is how to maintain those living cells, to make them viable and functional in the device,” Lu says. “They require humidity, nutrients, and some require oxygen. The second challenge is how to prevent them from escaping from the material.”

To get around these roadblocks, others have used freeze-dried chemical extracts from genetically engineered cells, incorporating them into paper to create low-cost, virus-detecting diagnostic strips. But extracts, Lu says, are not the same as living cells, which can maintain their functionality over a longer period of time and may have higher sensitivity for detecting pathogens.

Other groups have seeded onto thin rubber films to make soft, “living” actuators, or robots. When bent repeatedly, however, these films can crack, allowing the to leak out.

A lively host

Zhao’s group in MIT’s Soft Active Materials Laboratory has developed a material that may be ideal for hosting living cells. For the past few years, his team has come up with various formulations of hydrogel—a tough, highly stretchable, biocompatible material made from a mix of polymer and water. Their latest designs have contained up to 95 percent water, providing an environment which Zhao and Lu recognized might be suitable for sustaining . The material also resists cracking even when repeatedly stretched and pulled—a property that could help contain cells within the material.

The two groups teamed up to integrate Lu’s genetically programmed into Zhao’s sheets of hydrogel material. They first fabricated layers of hydrogel and patterned narrow channels within the layers using 3-D printing and micromolding techniques. They fused the hydrogel to a layer of elastomer, or rubber, that is porous enough to let in oxygen. They then injected E. coli cells into the hydrogel’s channels. The cells were programmed to fluoresce, or light up, when in contact with certain chemicals that pass through the hydrogel, in this case a natural compound known as DAPG.

The researchers then soaked the hydrogel/elastomer material in a bath of nutrients which infused throughout the hydrogel and helped to keep the bacterial cells alive and active for several days.

To demonstrate the material’s potential uses, the researchers first fabricated a sheet of the material with four separate, narrow channels, each containing a type of bacteria engineered to glow green in response to a different chemical compound. They found each channel reliably lit up when exposed to its respective chemical.

Next, the team fashioned the material into a bandage, or “living patch,” patterned with channels containing bacteria sensitive to rhamnose, a naturally occurring sugar. The researchers swabbed a volunteer’s wrist with a cotton ball soaked in rhamnose, then applied the hydrogel patch, which instantly lit up in response to the chemical.

Finally, the researchers fabricated a hydrogel/elastomer glove whose fingertips contained swirl-like channels, each of which they filled with different chemical-sensing bacterial . Each fingertip glowed in response to picking up a cotton ball soaked with a respective compound.

The group has also developed a theoretical model to help guide others in designing similar living materials and devices.

“The model helps us to design living devices more efficiently,” Zhao says. “It tells you things like the thickness of the hydrogel layer you should use, the distance between channels, how to pattern the channels, and how much bacteria to use.”

Ultimately, Zhao envisions products made from living materials, such as gloves and rubber soles lined with chemical-sensing , or bandages, patches, and even clothing that may detect signs of infection or disease. website

This article was posted on phys.org

by Jennifer Chu

 

 

website